| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR MYH1 MYH4 MYH8 MYH10 CTTNBP2 MYL2 KLHL1 ANK2 MYO5A MAP2 STRBP SYNE1 SPTAN1 TTLL5 SPTBN1 CEP290 ESPNL JAKMIP3 ACTR2 CCDC88C LRPPRC SETD2 DST MACO1 ROCK1 PPP1R9B PLEC DNAI7 DMD CACYBP MYO18B CAMSAP1 STK38L MRTFA MX2 | 1.69e-11 | 1099 | 182 | 36 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH4 MYH8 MYH10 MYL2 KLHL1 MYO5A MAP2 SYNE1 SPTAN1 SPTBN1 ESPNL ACTR2 LRPPRC DST PPP1R9B PLEC DMD MYO18B STK38L MRTFA | 2.98e-09 | 479 | 182 | 21 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH4 MYH8 MYH10 MYO5A SYNE1 SPTAN1 SPTBN1 ESPNL ACTR2 LRPPRC PPP1R9B PLEC MYO18B | 2.25e-08 | 227 | 182 | 14 | GO:0051015 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH4 MYH8 MYH10 MYO5A MAP2 SPTAN1 SPTBN1 RYR2 SYT1 AKT1 UNC13C CAMSAP1 | 2.00e-07 | 230 | 182 | 13 | GO:0005516 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.20e-07 | 130 | 182 | 10 | GO:0005200 | |
| GeneOntologyMolecularFunction | calcium ion binding | CLGN MYL1 MYL2 CALB2 MYO5A CALU SPTAN1 RCN2 EFHD2 RYR2 S100A1 S100A2 MICU3 DST CDH20 OTOF ITGB1BP2 VCAN SYT1 UNC13C PLCB2 PRKCSH ADGRE1 | 3.59e-07 | 749 | 182 | 23 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | TPR KRT5 MYH8 COL12A1 MYL1 MYL2 ANK2 MAP2 POTEF SPTAN1 SPTBN1 MPZL1 MRPS35 ACTR2 POTEE KRT76 DST VCAN KRT222 RIMS1 PLEC DMD POTEI | 6.73e-06 | 891 | 182 | 23 | GO:0005198 |
| GeneOntologyMolecularFunction | tubulin binding | TPR MAP2 STRBP TTLL5 CEP290 JAKMIP3 CCDC88C LRPPRC SETD2 DST MACO1 DNAI7 CACYBP CAMSAP1 MX2 | 9.37e-06 | 428 | 182 | 15 | GO:0015631 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.34e-05 | 38 | 182 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 4.33e-05 | 43 | 182 | 5 | GO:0008307 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.16e-04 | 11 | 182 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | microtubule binding | MAP2 STRBP CEP290 JAKMIP3 CCDC88C LRPPRC DST MACO1 DNAI7 CAMSAP1 MX2 | 1.27e-04 | 308 | 182 | 11 | GO:0008017 |
| GeneOntologyMolecularFunction | dystroglycan binding | 1.54e-04 | 12 | 182 | 3 | GO:0002162 | |
| GeneOntologyMolecularFunction | kinase binding | TPR HIF1A HSP90B2P ANK2 MYO5A MAP2 POTEF NCK1 JAKMIP3 STK11IP GADD45A RYR2 POTEE WWC2 PPP1R9B AKT1 PRKCSH RIMS1 LRBA POTEI SMCR8 | 2.10e-04 | 969 | 182 | 21 | GO:0019900 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH4 MYH8 MYH10 HSP90B2P DDX12P MYO5A EIF4A3 SMC1A WRN SMC4 RFC5 DDX46 SMARCA2 VCP | 5.22e-04 | 614 | 182 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 5.42e-04 | 111 | 182 | 6 | GO:0003727 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.70e-04 | 42 | 182 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TPR UIMC1 A1CF ANK2 PAGE4 KMT5A SYNE1 NCK1 TUT1 TRIP11 TAB3 KCTD17 WWC2 IGF2BP2 AKAP9 TRIM17 SMARCA2 TMF1 SMARCE1 PHF14 MYOCD CACYBP HDGFL2 MRTFA VCP | 6.01e-04 | 1356 | 182 | 25 | GO:0060090 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.48e-04 | 118 | 182 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | cytoskeletal regulatory protein binding | 8.11e-04 | 5 | 182 | 2 | GO:0005519 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TPR UIMC1 A1CF ANK2 PAGE4 KMT5A SYNE1 NCK1 TUT1 TRIP11 KCTD17 WWC2 IGF2BP2 TRIM17 SMARCA2 TMF1 SMARCE1 PHF14 MYOCD HDGFL2 MRTFA VCP | 9.05e-04 | 1160 | 182 | 22 | GO:0030674 |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 1.31e-03 | 24 | 182 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | histone reader activity | 1.66e-03 | 26 | 182 | 3 | GO:0140566 | |
| GeneOntologyMolecularFunction | calcium ion sensor activity | 1.68e-03 | 7 | 182 | 2 | GO:0061891 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 1.68e-03 | 7 | 182 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | metal ion sensor activity | 2.23e-03 | 8 | 182 | 2 | GO:0140784 | |
| GeneOntologyMolecularFunction | poly(A) binding | 2.29e-03 | 29 | 182 | 3 | GO:0008143 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH4 MYH8 HSP90B2P DDX12P EIF4A3 SMC1A WRN SMC4 RFC5 DDX46 VCP | 2.46e-03 | 441 | 182 | 11 | GO:0016887 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH4 IQSEC3 MYH8 MYH10 HSP90B2P MYL1 CTTNBP2 MYL2 KLHL1 ANK2 MYO5A POTEF ZBED2 SPTAN1 SPTBN1 ESPNL NCK1 SPECC1L ACTR2 RYR2 CCDC88C POTEE AKAP9 ROCK1 PPP1R9B PLEC POTEI MYO18B MRTFA | 1.16e-09 | 912 | 178 | 29 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 8.81e-07 | 153 | 178 | 10 | GO:0030048 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | IQSEC3 MYH10 HSP90B2P CTTNBP2 MYL2 KLHL1 MYO5A POTEF ZBED2 SPTAN1 SPTBN1 ESPNL NCK1 SPECC1L ACTR2 POTEE ROCK1 PPP1R9B PLEC POTEI MYO18B MRTFA | 1.74e-06 | 803 | 178 | 22 | GO:0030036 |
| GeneOntologyBiologicalProcess | microtubule-based process | TPR HIF1A MYO5A MAP2 IFT57 SMC1A ZBED2 TTLL5 CEP290 SPECC1L GADD45A PGK2 ACTR2 CCDC88C LRPPRC SETD2 DST AKAP9 NAT10 TMF1 ROCK1 DNAI7 CAMSAP1 CENATAC VCP | 4.61e-06 | 1058 | 178 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.47e-05 | 127 | 178 | 8 | GO:0070252 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | MAP2 SPTAN1 SPTBN1 SPECC1L SSRP1 CCDC88C SMARCE1 PPP1R9B CAMSAP1 SMCR8 VCP | 4.72e-05 | 291 | 178 | 11 | GO:0032984 |
| GeneOntologyBiologicalProcess | peripheral nervous system myelin maintenance | 5.11e-05 | 9 | 178 | 3 | GO:0032287 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT5 MYH10 HSP90B2P COL12A1 MYL2 MYO5A MAP2 ZBED2 SPTAN1 SPTBN1 ESPNL NCK1 SPECC1L ACTR2 CCDC88C KRT76 AKAP9 ROCK1 PPP1R9B PLEC CAMSAP1 | 8.25e-05 | 957 | 178 | 21 | GO:0097435 |
| GeneOntologyBiologicalProcess | heart development | HIF1A MYH10 ANKS6 MYL2 ANK2 IFT57 SYNE1 CEP290 TRIP11 RBM20 RYR2 SETD2 VCAN ROCK1 MYOCD PLEC CACYBP MYO18B | 1.02e-04 | 757 | 178 | 18 | GO:0007507 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.22e-04 | 89 | 178 | 6 | GO:1901880 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.41e-04 | 31 | 178 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | DNA repair | PDS5B UIMC1 DDX12P KMT5A SMC1A WRN SMC4 SSRP1 RFC5 GADD45A ACTR2 SETD2 SMARCA2 SMARCE1 HDGFL2 VCP | 1.63e-04 | 648 | 178 | 16 | GO:0006281 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TPR MAP2 SMC1A ZBED2 TTLL5 CEP290 SPECC1L GADD45A CCDC88C SETD2 DST AKAP9 NAT10 ROCK1 CAMSAP1 CENATAC VCP | 1.73e-04 | 720 | 178 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | secretory granule localization | 2.03e-04 | 34 | 178 | 4 | GO:0032252 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | MYH10 MYL2 ANK2 SYNE1 ZBED6 SMARCA2 AKT1 MYOCD PLEC DMD CACYBP MYO18B HDGFL2 MRTFA | 2.18e-04 | 531 | 178 | 14 | GO:0042692 |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 2.21e-04 | 3 | 178 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TPR HIF1A MYO5A MAP2 SYNE1 SPTAN1 SPTBN1 MAP3K20 SMC4 NCK1 SPECC1L KCTD17 CCDC88C AKAP9 CASKIN1 NAT10 SMARCA2 SYT1 ROCK1 SMARCE1 AKT1 RIMS1 CAMSAP1 CENATAC SMCR8 | 2.26e-04 | 1342 | 178 | 25 | GO:0033043 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 2.28e-04 | 35 | 178 | 4 | GO:0099188 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 2.31e-04 | 100 | 178 | 6 | GO:0043242 | |
| GeneOntologyBiologicalProcess | DNA damage response | PDS5B UIMC1 DDX12P UACA KMT5A SMC1A WRN MAP3K20 SMC4 SSRP1 RFC5 GADD45A ACTR2 PPP4R3A SETD2 SMARCA2 SMARCE1 AKT1 HDGFL2 VCP | 2.41e-04 | 959 | 178 | 20 | GO:0006974 |
| GeneOntologyBiologicalProcess | endomembrane system organization | MYH10 DNAJC13 ANK2 MYO5A SYNE1 ZBED2 SPTBN1 TRIP11 PALS1 AKAP9 OTOF TMF1 SYT1 AKT1 RIMS1 PLEC | 2.46e-04 | 672 | 178 | 16 | GO:0010256 |
| GeneOntologyBiologicalProcess | protein depolymerization | 2.58e-04 | 144 | 178 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 2.58e-04 | 144 | 178 | 7 | GO:0043244 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 2.66e-04 | 15 | 178 | 3 | GO:0030049 | |
| GeneOntologyBiologicalProcess | cell cycle process | PDS5B TPR UIMC1 MYH10 DDX12P KMT5A SMC1A ZBED2 SPTBN1 WRN MAP3K20 SLFN12 SMC4 GADD45A ACTR2 SETD2 NAT10 SMARCA2 ROCK1 SMARCE1 PPP1R9B AKT1 PLEC PUM1 CENATAC VCP | 2.77e-04 | 1441 | 178 | 26 | GO:0022402 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 3.01e-04 | 105 | 178 | 6 | GO:1901879 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 3.15e-04 | 38 | 178 | 4 | GO:0007026 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric-oxide synthase activity | 3.26e-04 | 16 | 178 | 3 | GO:0051000 | |
| GeneOntologyBiologicalProcess | postsynapse organization | IQSEC3 MYH10 POTEF ACTR2 POTEE CASKIN1 PPP1R9B AKT1 POTEI STK38L | 4.05e-04 | 313 | 178 | 10 | GO:0099173 |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 4.31e-04 | 259 | 178 | 9 | GO:0051651 | |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 4.39e-04 | 4 | 178 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell action potential | 4.39e-04 | 4 | 178 | 2 | GO:0098910 | |
| GeneOntologyBiologicalProcess | NADH metabolic process | 4.65e-04 | 42 | 178 | 4 | GO:0006734 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 4.65e-04 | 42 | 178 | 4 | GO:0031114 | |
| GeneOntologyBiologicalProcess | muscle structure development | MYH10 MYL2 ANK2 SYNE1 ITGA7 RYR2 ZBED6 ITGB1BP2 SMARCA2 SMARCE1 AKT1 MYOCD PLEC DMD CACYBP MYO18B HDGFL2 MRTFA | 4.65e-04 | 858 | 178 | 18 | GO:0061061 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 4.69e-04 | 18 | 178 | 3 | GO:0033275 | |
| GeneOntologyBiologicalProcess | myelin maintenance | 4.69e-04 | 18 | 178 | 3 | GO:0043217 | |
| GeneOntologyBiologicalProcess | actin filament organization | MYH10 HSP90B2P MYO5A ZBED2 SPTAN1 SPTBN1 ESPNL NCK1 SPECC1L ACTR2 ROCK1 PPP1R9B PLEC | 4.94e-04 | 509 | 178 | 13 | GO:0007015 |
| GeneOntologyCellularComponent | sarcomere | MYH1 MYH4 MYH8 MYL1 MYL2 ANK2 SYNE1 SPTAN1 SPTBN1 RYR2 S100A1 DST ITGB1BP2 PLEC DMD MYO18B | 4.81e-10 | 249 | 179 | 16 | GO:0030017 |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH4 MYH8 MYL1 MYL2 ANK2 SYNE1 SPTAN1 SPTBN1 RYR2 S100A1 DST ITGB1BP2 PLEC DMD MYO18B | 1.83e-09 | 273 | 179 | 16 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH4 MYH8 MYL1 MYL2 ANK2 SYNE1 SPTAN1 SPTBN1 RYR2 S100A1 DST ITGB1BP2 PLEC DMD MYO18B | 4.37e-09 | 290 | 179 | 16 | GO:0043292 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 KRT5 MYH4 MYH8 MYH10 MYL1 MYL2 CASP14 ANK2 MYO5A MAP2 POTEF SYNE1 SPTAN1 TTLL5 SPTBN1 SPECC1L RYR2 S100A1 POTEE LRPPRC KRT76 DST ITGB1BP2 KRT222 PLEC DNAI7 DMD POTEI MYO18B CAMSAP1 MX2 | 5.82e-09 | 1179 | 179 | 32 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 KRT5 MYH4 MYH8 MYH10 MYL1 MYL2 CASP14 ANK2 MYO5A MAP2 POTEF SYNE1 SPTAN1 TTLL5 SPTBN1 SPECC1L RYR2 S100A1 POTEE LRPPRC KRT76 DST ITGB1BP2 KRT222 PLEC DNAI7 DMD POTEI MYO18B CAMSAP1 MX2 | 6.85e-09 | 1187 | 179 | 32 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH4 MYH8 MYH10 MYL1 CTTNBP2 MYL2 CALB2 MYO5A MAP2 POTEF SPTAN1 SPTBN1 SPECC1L ACTR2 POTEE DST PPP1R9B POTEI MYO18B STK38L | 2.50e-08 | 576 | 179 | 21 | GO:0015629 |
| GeneOntologyCellularComponent | myosin complex | 3.78e-08 | 59 | 179 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin II complex | 1.17e-07 | 28 | 179 | 6 | GO:0016460 | |
| GeneOntologyCellularComponent | A band | 2.90e-07 | 52 | 179 | 7 | GO:0031672 | |
| GeneOntologyCellularComponent | myosin filament | 2.01e-06 | 25 | 179 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | Z disc | 6.30e-06 | 151 | 179 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | muscle myosin complex | 8.73e-06 | 16 | 179 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | I band | 1.35e-05 | 166 | 179 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | MYH1 FAM184A SYNE1 PABPC4 PABPC4L STK31 RBM20 IGF2BP2 ROCK1 PUM1 VCP | 2.15e-05 | 269 | 179 | 11 | GO:0036464 |
| GeneOntologyCellularComponent | ribonucleoprotein granule | MYH1 FAM184A SYNE1 PABPC4 PABPC4L STK31 RBM20 IGF2BP2 ROCK1 PUM1 VCP | 3.89e-05 | 287 | 179 | 11 | GO:0035770 |
| GeneOntologyCellularComponent | axon | RANGAP1 HIF1A MYH10 CALB2 MYO5A MAP2 POTEF SPTAN1 SPTBN1 POTEE PALS1 DST MACO1 SYT1 PPP1R9B UNC13C PLEC DMD POTEI PUM1 | 8.18e-05 | 891 | 179 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | cell cortex | MYH10 CTTNBP2 CALB2 POTEF SPTAN1 SPTBN1 ACTR2 DST PPP1R9B AKT1 UNC13C RIMS1 | 8.91e-05 | 371 | 179 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | cuticular plate | 1.66e-04 | 13 | 179 | 3 | GO:0032437 | |
| GeneOntologyCellularComponent | postsynapse | IQSEC3 MYH10 CTTNBP2 ANK2 MYO5A MAP2 EIF4A3 SYNE1 SPTAN1 SPTBN1 ACTR2 VPS52 DST AKAP9 CASKIN1 PPP1R9B AKT1 RIMS1 DMD SMCR8 USP48 | 1.75e-04 | 1018 | 179 | 21 | GO:0098794 |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 1.78e-04 | 96 | 179 | 6 | GO:0010494 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT5 CASP14 MYO5A MAP2 POTEF TTLL5 SPECC1L POTEE LRPPRC KRT76 DST KRT222 PLEC DNAI7 DMD POTEI MYO18B CAMSAP1 MX2 | 2.68e-04 | 899 | 179 | 19 | GO:0099513 |
| GeneOntologyCellularComponent | sarcoplasm | 4.50e-04 | 114 | 179 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 4.56e-04 | 263 | 179 | 9 | GO:0045111 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 5.41e-04 | 19 | 179 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | intermediate filament | 7.78e-04 | 227 | 179 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | costamere | 8.43e-04 | 22 | 179 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 8.64e-04 | 129 | 179 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.23e-03 | 93 | 179 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 1.39e-03 | 26 | 179 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | dendritic branch | 1.49e-03 | 7 | 179 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | actin filament | 1.63e-03 | 146 | 179 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ANO2 MYH10 CTTNBP2 MYO5A MAP2 EIF4A3 SPTAN1 SPTBN1 DGKE AKAP9 CASKIN1 SYT1 AKT1 RIMS1 STK38L VCP | 1.81e-03 | 817 | 179 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | M band | 2.33e-03 | 31 | 179 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | microtubule organizing center | FAM184A DDX12P IFT57 TTLL5 CEP290 WRN ARMC9 SPECC1L PPP4R3A CCDC88C AKAP9 ZBED6 CROCC2 ROCK1 AKT1 CAMSAP1 CENATAC | 2.39e-03 | 919 | 179 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle membrane | 2.52e-03 | 9 | 179 | 2 | GO:0060203 | |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle | 2.52e-03 | 9 | 179 | 2 | GO:0060199 | |
| GeneOntologyCellularComponent | spectrin | 2.52e-03 | 9 | 179 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 2.55e-03 | 32 | 179 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 2.55e-03 | 32 | 179 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | intercalated disc | 2.76e-03 | 68 | 179 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | bBAF complex | 3.14e-03 | 10 | 179 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 3.14e-03 | 10 | 179 | 2 | GO:0031390 | |
| GeneOntologyCellularComponent | unconventional myosin complex | 3.81e-03 | 11 | 179 | 2 | GO:0016461 | |
| GeneOntologyCellularComponent | hemidesmosome | 3.81e-03 | 11 | 179 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | paranodal junction | 3.81e-03 | 11 | 179 | 2 | GO:0033010 | |
| GeneOntologyCellularComponent | anchoring junction | MYH1 CALB2 ANK2 SPTAN1 MPZL1 NCK1 SPECC1L ITGA7 ACTR2 CCDC88C PALS1 DST CDH20 PPP1R9B AKT1 PLEC DMD | 4.39e-03 | 976 | 179 | 17 | GO:0070161 |
| HumanPheno | Abnormality of the Achilles tendon | 1.25e-05 | 64 | 64 | 7 | HP:0005109 | |
| HumanPheno | Abnormality of skeletal muscle fiber size | 1.64e-05 | 121 | 64 | 9 | HP:0012084 | |
| HumanPheno | Back pain | 4.26e-05 | 77 | 64 | 7 | HP:0003418 | |
| HumanPheno | Type 1 muscle fiber atrophy | 6.08e-05 | 18 | 64 | 4 | HP:0011807 | |
| HumanPheno | Progressive muscle weakness | 8.08e-05 | 85 | 64 | 7 | HP:0003323 | |
| HumanPheno | Weakness of muscles of respiration | 8.67e-05 | 116 | 64 | 8 | HP:0004347 | |
| HumanPheno | Increased variability in muscle fiber diameter | 8.67e-05 | 116 | 64 | 8 | HP:0003557 | |
| MousePheno | abnormal muscle fiber morphology | MYH4 AARS1 MYH10 COL12A1 MYL2 SYNE1 SPTBN1 ITGA7 RBM20 RYR2 DST AKT1 MYOCD PLEC DMD MRTFA VCP | 2.42e-06 | 406 | 154 | 17 | MP:0004087 |
| MousePheno | impaired muscle contractility | MYH1 MYH4 AARS1 MYH10 A1CF MYL2 ANK2 RBM20 RYR2 S100A1 CKM DST DMD | 2.48e-05 | 297 | 154 | 13 | MP:0000738 |
| MousePheno | abnormal myocardial fiber morphology | 3.48e-05 | 183 | 154 | 10 | MP:0000278 | |
| MousePheno | abnormal fetal cardiomyocyte morphology | 3.78e-05 | 35 | 154 | 5 | MP:0008788 | |
| MousePheno | abnormal myocardium layer morphology | AARS1 HIF1A MYH10 A1CF MYL2 SPTAN1 SPTBN1 RBM20 RYR2 AKT1 MYOCD PLEC DMD MYO18B MRTFA | 5.28e-05 | 414 | 154 | 15 | MP:0005329 |
| MousePheno | abnormal myocardial fiber physiology | 5.97e-05 | 90 | 154 | 7 | MP:0004215 | |
| MousePheno | abnormal heart layer morphology | AARS1 HIF1A MYH10 A1CF MYL2 SPTAN1 SPTBN1 RBM20 RYR2 AKT1 MYOCD PLEC DMD MYO18B MRTFA | 6.56e-05 | 422 | 154 | 15 | MP:0010545 |
| MousePheno | impaired skeletal muscle contractility | 1.17e-04 | 44 | 154 | 5 | MP:0002841 | |
| MousePheno | abnormal muscle morphology | MYH1 MYH4 AARS1 HIF1A MYH10 A1CF COL12A1 MYL2 SYNE1 SPTAN1 SPTBN1 ITGA7 RBM20 RYR2 CKM DST ZBED6 SYT1 ROCK1 AKT1 MYOCD PLEC DMD MYO18B MRTFA VCP | 1.78e-04 | 1106 | 154 | 26 | MP:0002108 |
| MousePheno | decreased cardiac muscle contractility | 1.81e-04 | 223 | 154 | 10 | MP:0005140 | |
| Domain | EF-hand-dom_pair | MYL1 MYL2 CALB2 CALU SPTAN1 RCN2 EFHD2 RYR2 S100A1 S100A2 MICU3 DST PLCB2 PRKCSH DMD | 1.19e-07 | 287 | 179 | 15 | IPR011992 |
| Domain | - | MYL1 MYL2 CALB2 CALU SPTAN1 RCN2 EFHD2 RYR2 S100A1 S100A2 MICU3 DST PLCB2 DMD | 2.32e-07 | 261 | 179 | 14 | 1.10.238.10 |
| Domain | Spectrin_repeat | 2.82e-07 | 29 | 179 | 6 | IPR002017 | |
| Domain | EFh | MYL1 MYL2 CALB2 CALU SPTAN1 RCN2 EFHD2 RYR2 S100A1 MICU3 DST | 3.66e-07 | 158 | 179 | 11 | SM00054 |
| Domain | EF_HAND_2 | MYL1 MYL2 CALB2 CALU SPTAN1 RCN2 EFHD2 RYR2 S100A1 S100A2 MICU3 DST PRKCSH | 3.68e-07 | 231 | 179 | 13 | PS50222 |
| Domain | EF_hand_dom | MYL1 MYL2 CALB2 CALU SPTAN1 RCN2 EFHD2 RYR2 S100A1 S100A2 MICU3 DST PRKCSH | 3.87e-07 | 232 | 179 | 13 | IPR002048 |
| Domain | SPEC | 5.25e-07 | 32 | 179 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.25e-07 | 32 | 179 | 6 | IPR018159 | |
| Domain | Myosin-like_IQ_dom | 7.97e-07 | 19 | 179 | 5 | IPR027401 | |
| Domain | - | 7.97e-07 | 19 | 179 | 5 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 1.52e-06 | 38 | 179 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.52e-06 | 38 | 179 | 6 | PS51456 | |
| Domain | Myosin_head | 1.52e-06 | 38 | 179 | 6 | PF00063 | |
| Domain | MYSc | 1.52e-06 | 38 | 179 | 6 | SM00242 | |
| Domain | EF-hand_1 | 2.11e-06 | 152 | 179 | 10 | PF00036 | |
| Domain | Spectrin | 2.24e-06 | 23 | 179 | 5 | PF00435 | |
| Domain | ACTININ_2 | 2.24e-06 | 23 | 179 | 5 | PS00020 | |
| Domain | ACTININ_1 | 2.24e-06 | 23 | 179 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.24e-06 | 23 | 179 | 5 | IPR001589 | |
| Domain | EF_HAND_1 | MYL2 CALB2 CALU SPTAN1 RCN2 EFHD2 S100A1 S100A2 MICU3 DST PRKCSH | 4.51e-06 | 204 | 179 | 11 | PS00018 |
| Domain | IQ | 5.24e-06 | 71 | 179 | 7 | PF00612 | |
| Domain | CH | 6.32e-06 | 73 | 179 | 7 | PS50021 | |
| Domain | EF_Hand_1_Ca_BS | 7.43e-06 | 175 | 179 | 10 | IPR018247 | |
| Domain | CH-domain | 7.57e-06 | 75 | 179 | 7 | IPR001715 | |
| Domain | Myosin_N | 1.03e-05 | 15 | 179 | 4 | PF02736 | |
| Domain | Myosin_N | 1.03e-05 | 15 | 179 | 4 | IPR004009 | |
| Domain | Myosin_tail_1 | 2.25e-05 | 18 | 179 | 4 | PF01576 | |
| Domain | Myosin_tail | 2.25e-05 | 18 | 179 | 4 | IPR002928 | |
| Domain | Actin/actin-like_CS | 2.25e-05 | 18 | 179 | 4 | IPR020902 | |
| Domain | IQ_motif_EF-hand-BS | 2.53e-05 | 90 | 179 | 7 | IPR000048 | |
| Domain | ACTINS_ACT_LIKE | 2.83e-05 | 19 | 179 | 4 | PS01132 | |
| Domain | IQ | 3.13e-05 | 93 | 179 | 7 | PS50096 | |
| Domain | CH | 3.68e-05 | 65 | 179 | 6 | SM00033 | |
| Domain | Ank_2 | ANKS6 CTTNBP2 ANK2 UACA POTEF ESPNL POTEE CASKIN1 OSBPL1A POTEI | 4.40e-05 | 215 | 179 | 10 | PF12796 |
| Domain | CH | 5.62e-05 | 70 | 179 | 6 | PF00307 | |
| Domain | - | 6.09e-05 | 71 | 179 | 6 | 1.10.418.10 | |
| Domain | Ank | ANKS6 CTTNBP2 ANK2 UACA POTEF ESPNL POTEE CASKIN1 OSBPL1A POTEI | 7.21e-05 | 228 | 179 | 10 | PF00023 |
| Domain | IQ | 1.28e-04 | 81 | 179 | 6 | SM00015 | |
| Domain | - | ANKS6 CTTNBP2 ANK2 UACA POTEF ESPNL POTEE CASKIN1 OSBPL1A POTEI | 1.44e-04 | 248 | 179 | 10 | 1.25.40.20 |
| Domain | ANK | ANKS6 CTTNBP2 ANK2 UACA POTEF ESPNL POTEE CASKIN1 OSBPL1A POTEI | 1.59e-04 | 251 | 179 | 10 | SM00248 |
| Domain | ANK_REPEAT | ANKS6 CTTNBP2 ANK2 UACA POTEF ESPNL POTEE CASKIN1 OSBPL1A POTEI | 1.70e-04 | 253 | 179 | 10 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKS6 CTTNBP2 ANK2 UACA POTEF ESPNL POTEE CASKIN1 OSBPL1A POTEI | 1.75e-04 | 254 | 179 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | ANKS6 CTTNBP2 ANK2 UACA POTEF ESPNL POTEE CASKIN1 OSBPL1A POTEI | 1.75e-04 | 254 | 179 | 10 | PS50297 |
| Domain | Actin | 2.10e-04 | 31 | 179 | 4 | IPR004000 | |
| Domain | Actin | 2.10e-04 | 31 | 179 | 4 | PF00022 | |
| Domain | ACTIN | 2.10e-04 | 31 | 179 | 4 | SM00268 | |
| Domain | Ankyrin_rpt | ANKS6 CTTNBP2 ANK2 UACA POTEF ESPNL POTEE CASKIN1 OSBPL1A POTEI | 2.25e-04 | 262 | 179 | 10 | IPR002110 |
| Domain | EF-hand_6 | 2.31e-04 | 13 | 179 | 3 | PF13405 | |
| Domain | Actin_CS | 4.42e-04 | 16 | 179 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 5.33e-04 | 17 | 179 | 3 | PS00432 | |
| Domain | SMC | 8.96e-04 | 5 | 179 | 2 | IPR024704 | |
| Domain | Myosin_S1_N | 8.96e-04 | 5 | 179 | 2 | IPR008989 | |
| Domain | - | 1.34e-03 | 6 | 179 | 2 | 2.40.50.90 | |
| Domain | ZF_BED | 1.34e-03 | 6 | 179 | 2 | PS50808 | |
| Domain | - | 1.34e-03 | 6 | 179 | 2 | 3.90.1290.10 | |
| Domain | zf-BED | 1.34e-03 | 6 | 179 | 2 | PF02892 | |
| Domain | SMC_hinge | 1.34e-03 | 6 | 179 | 2 | SM00968 | |
| Domain | Staphylococal_nuclease_OB-fold | 1.34e-03 | 6 | 179 | 2 | IPR016071 | |
| Domain | SMC_hinge | 1.34e-03 | 6 | 179 | 2 | PF06470 | |
| Domain | SMC_hinge | 1.34e-03 | 6 | 179 | 2 | IPR010935 | |
| Domain | EF-hand_7 | 1.35e-03 | 85 | 179 | 5 | PF13499 | |
| Domain | EF-hand_5 | 1.70e-03 | 25 | 179 | 3 | PF13202 | |
| Domain | RPEL | 1.86e-03 | 7 | 179 | 2 | PS51073 | |
| Domain | RPEL | 1.86e-03 | 7 | 179 | 2 | SM00707 | |
| Domain | Plectin | 1.86e-03 | 7 | 179 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.86e-03 | 7 | 179 | 2 | IPR001101 | |
| Domain | RPEL | 1.86e-03 | 7 | 179 | 2 | PF02755 | |
| Domain | RPEL_repeat | 1.86e-03 | 7 | 179 | 2 | IPR004018 | |
| Domain | PLEC | 1.86e-03 | 7 | 179 | 2 | SM00250 | |
| Domain | dsRBD_dom | 2.38e-03 | 28 | 179 | 3 | IPR014720 | |
| Domain | RecF/RecN/SMC_N | 2.46e-03 | 8 | 179 | 2 | IPR003395 | |
| Domain | SMC_N | 2.46e-03 | 8 | 179 | 2 | PF02463 | |
| Domain | C2 | 2.49e-03 | 142 | 179 | 6 | PS50004 | |
| Domain | - | 3.06e-03 | 148 | 179 | 6 | 2.60.40.150 | |
| Pathway | KEGG_TIGHT_JUNCTION | 4.30e-06 | 132 | 133 | 9 | M11355 | |
| Pubmed | PDS5B UIMC1 MYH1 KRT5 MYH4 RANGAP1 MYH8 MYH10 ANK2 MYO5A STRBP EIF4A3 POTEF SYNE1 SPTAN1 SPTBN1 PABPC4 SMC4 MRPS35 SSRP1 STK31 PGK2 ACTR2 RYR2 KNOP1 POTEE LRPPRC KRT76 DST FAM186A PPP1R9B PHF14 DLST RIMS1 PLEC DMD POTEI HDGFL2 | 2.29e-16 | 1442 | 185 | 38 | 35575683 | |
| Pubmed | TPR IQSEC3 RANGAP1 MYH10 DNAJC13 CTTNBP2 ANK2 TRA2B UACA MYO5A SYNE1 SPTAN1 SPTBN1 EFHD2 SPECC1L JAKMIP3 TRIP11 CCDC88C PALS1 LRPPRC DST AKAP9 CASKIN1 NAT10 SYT1 ROCK1 PPP1R9B RIMS1 CAMSAP1 GOLGA1 LRRFIP1 | 9.01e-16 | 963 | 185 | 31 | 28671696 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPR UIMC1 RANGAP1 MYH10 MYL1 TRA2B UACA MYO5A EIF4A3 SYNE1 SMC1A SPTAN1 SPTBN1 PABPC4 MAP3K20 SMC4 EFHD2 SPECC1L SSRP1 ACTR2 LRPPRC DDX46 DST NAT10 PPP1R9B PLEC ADGRA3 VCP LRRFIP1 | 3.16e-14 | 949 | 185 | 29 | 36574265 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPR UIMC1 RANGAP1 MYH10 HSP90B2P MYL1 EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 SMC4 NAP1L4 SSRP1 RFC5 PGK2 ACTR2 PPP4R3A CKM SLC4A1AP RABGAP1L SMARCA2 ROCK1 PRKCSH PLEC HDGFL2 LRRFIP1 | 9.80e-14 | 847 | 185 | 27 | 35235311 |
| Pubmed | PDS5B TPR RANGAP1 MYH10 TRA2B UACA MYO5A EIF4A3 SPTAN1 SPTBN1 EFHD2 SPECC1L RFC5 ACTR2 POTEE DDX46 DST NAT10 PPP1R9B DLST PLEC HDGFL2 VCP LRRFIP1 | 1.59e-13 | 660 | 185 | 24 | 32780723 | |
| Pubmed | TACO1 RANGAP1 FAM184A DNAJC13 ANK2 UACA MYO5A MAP2 CALU SYNE1 SPTAN1 TTLL5 SPTBN1 RCN2 NAP1L4 MRPS35 DGKE TNFRSF10B SSRP1 GRAMD1B LRPPRC AKAP9 SLC4A1AP MACO1 NAT10 GKAP1 DLST TYW1 PRKCSH CACYBP SMCR8 USP48 HDGFL2 VCP | 6.13e-13 | 1487 | 185 | 34 | 33957083 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR KRT5 AARS1 RANGAP1 MYH10 MYO5A CALU SMC1A SPTAN1 SPTBN1 PABPC4 RCN2 SMC4 NAP1L4 MRPS35 EFHD2 SSRP1 ACTR2 GSS PALS1 LRPPRC IGF2BP2 DDX46 DST PRKCSH PLEC CACYBP STK38L HDGFL2 VCP | 6.18e-13 | 1149 | 185 | 30 | 35446349 |
| Pubmed | KRT5 TRA2B UACA STRBP EIF4A3 POTEF SMC1A PABPC4 RCN2 SMC4 NAP1L4 MRPS35 TUT1 SSRP1 RFC5 POTEE LRPPRC IGF2BP2 KRT76 DDX46 RABGAP1L KRT222 NAT10 OSBPL1A SMARCE1 POTEI STK38L ENO3 VCP TGS1 | 6.75e-13 | 1153 | 185 | 30 | 29845934 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPR MYH1 MYH4 AARS1 MYH8 MYH10 CALU STRBP SPTAN1 SPTBN1 PABPC4 RCN2 SMC4 SPECC1L RFC5 LRPPRC IGF2BP2 DLST PRKCSH PLEC LRBA VCP MX2 | 8.40e-13 | 647 | 185 | 23 | 26618866 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B TPR KRT5 RANGAP1 CASP14 TRA2B MYO5A STRBP EIF4A3 SYNE1 SMC1A CEP290 PABPC4 MPZL1 SMC4 SPECC1L SSRP1 RFC5 ACTR2 LRPPRC IGF2BP2 DDX46 DST NAT10 PRKCSH PLEC PUM1 VCP | 1.33e-12 | 1024 | 185 | 28 | 24711643 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | TPR ANK2 STRBP POTEF SMC1A SPTBN1 PABPC4 WRN SSRP1 KNOP1 POTEE DDX46 NAT10 PHF14 PLEC POTEI | 1.69e-12 | 271 | 185 | 16 | 32433965 |
| Pubmed | KRT5 RANGAP1 MYH10 DNAJC13 MYO5A IFT57 CALU SPTAN1 SPTBN1 CEP290 MPZL1 RCN2 RBM20 TAB3 PPP4R3A WWC2 IGF2BP2 AKAP9 SLC4A1AP MACO1 NAT10 TMF1 ROCK1 PPP1R9B PRKCSH DMD CACYBP PUM1 | 2.36e-12 | 1049 | 185 | 28 | 27880917 | |
| Pubmed | TPR IQSEC3 RANGAP1 MYH10 HSP90B2P ANK2 TRA2B MYO5A MAP2 SPTAN1 SPTBN1 NAP1L4 MRPS35 RYR2 TAB3 GRAMD1B LRPPRC MICU3 CASKIN1 RABGAP1L SYT1 PPP1R9B DLST RIMS1 PLEC CACYBP CAMSAP1 VCP LRRFIP1 | 2.90e-12 | 1139 | 185 | 29 | 36417873 | |
| Pubmed | MYH8 COL12A1 MYL1 CTTNBP2 ANK2 UACA SYNE1 SMC1A SPTBN1 TRIP11 LRPPRC DST AKAP9 ITGB1BP2 PLEC MYO18B ENO3 ZSCAN23 VCP TGS1 | 3.07e-12 | 497 | 185 | 20 | 23414517 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | KRT5 MYH10 MYL1 TRA2B UACA MYO5A CALU SPTAN1 SPTBN1 PABPC4 RCN2 NAP1L4 EFHD2 SPECC1L SSRP1 RFC5 ACTR2 LRPPRC IGF2BP2 DLST PLEC VCP | 3.41e-12 | 626 | 185 | 22 | 33644029 |
| Pubmed | KRT5 IQSEC3 MYH10 DNAJC13 HSP90B2P CTTNBP2 ANK2 MYO5A MAP2 SYNE1 SPTAN1 SPTBN1 PABPC4 EFHD2 SPECC1L TRIP11 ACTR2 GRAMD1B LRPPRC KRT76 DST CASKIN1 VCAN GKAP1 SYT1 PPP1R9B DLST RIMS1 PLEC DMD VCP LRRFIP1 | 5.78e-12 | 1431 | 185 | 32 | 37142655 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPR KRT5 MYH10 TRA2B UACA MYO5A EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 MAP3K20 RCN2 SMC4 MRPS35 SPECC1L SSRP1 RFC5 ACTR2 KNOP1 PALS1 LRPPRC IGF2BP2 DST NAT10 PPP1R9B DLST PLEC CACYBP LRRFIP1 | 5.86e-12 | 1257 | 185 | 30 | 36526897 |
| Pubmed | TPR AARS1 RANGAP1 MYL1 CASP14 EIF4A3 PABPC4 RCN2 NAP1L4 MRPS35 SSRP1 ACTR2 KNOP1 LRPPRC TMF1 SMARCE1 PPP1R9B DLST PRKCSH PLEC CACYBP ENO3 HDGFL2 VCP | 6.37e-12 | 786 | 185 | 24 | 29128334 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | AARS1 RANGAP1 MAP2 CALU EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 LDHAL6B RCN2 SMC4 NAP1L4 EFHD2 ARMC9 TUT1 SSRP1 ACTR2 PPP4R3A GSS RTF1 THOP1 RPUSD2 ROCK1 PRKCSH PLEC LRBA CACYBP USP48 HDGFL2 VCP LRRFIP1 | 8.91e-12 | 1455 | 185 | 32 | 22863883 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | KRT5 DNAJC13 MYL1 CASP14 TRA2B SPTAN1 SPTBN1 PABPC4 RCN2 TAB3 KCTD17 IGF2BP2 MICU3 SLC4A1AP ROCK1 PLEC CACYBP STK38L ENO3 VCP | 2.46e-11 | 558 | 185 | 20 | 27591049 |
| Pubmed | RANGAP1 MYH10 UACA STRBP SPTAN1 SPTBN1 PABPC4 SPECC1L PALS1 LRPPRC NAT10 PPP1R9B PLEC PUM1 VCP | 2.51e-11 | 274 | 185 | 15 | 34244482 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PDS5B KRT5 RANGAP1 MYH10 DNAJC13 TRA2B MAP2 EIF4A3 SYNE1 SMC1A SPTAN1 SPTBN1 RCN2 NAP1L4 SSRP1 KNOP1 LRPPRC SETD2 IGF2BP2 DDX46 DST VCAN NAT10 SMARCE1 DLST PLEC VCP | 2.79e-11 | 1082 | 185 | 27 | 38697112 |
| Pubmed | RANGAP1 MYH10 DNAJC13 TRA2B EIF4A3 SMC1A SPTAN1 SPTBN1 RCN2 SMC4 NAP1L4 SSRP1 PPP4R3A LRPPRC DDX46 NAT10 PLEC LRBA CACYBP PUM1 VCP | 3.68e-11 | 638 | 185 | 21 | 33239621 | |
| Pubmed | PDS5B TPR AARS1 RANGAP1 MYH10 MYO5A STRBP SPTAN1 SPTBN1 PABPC4 SMC4 ACTR2 LRPPRC IGF2BP2 DDX46 DST NAT10 SMARCA2 PLEC PUM1 VCP | 5.64e-11 | 653 | 185 | 21 | 22586326 | |
| Pubmed | TPR AARS1 MYH10 EIF4A3 SPTAN1 SPTBN1 PABPC4 SMC4 TAB3 CCDC88C LRPPRC IGF2BP2 SLC4A1AP NAT10 ROCK1 DLST PLEC STK38L VCP | 1.53e-10 | 551 | 185 | 19 | 34728620 | |
| Pubmed | PDS5B TPR UIMC1 AARS1 TRA2B EIF4A3 SMC1A SMC4 NAP1L4 EFHD2 SSRP1 RFC5 PPP4R3A RTF1 SETD2 DDX46 NAT10 SMARCA2 SMARCE1 PHF14 PLEC CACYBP USP48 HDGFL2 VCP | 2.08e-10 | 1014 | 185 | 25 | 32416067 | |
| Pubmed | AARS1 MYH10 CALB2 ANK2 MYO5A SPTAN1 SPTBN1 NAP1L4 ACTR2 CASKIN1 SYT1 PPP1R9B LRRFIP1 | 4.39e-10 | 233 | 185 | 13 | 29518331 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | PDS5B RANGAP1 MYH10 EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 SMC4 NAP1L4 SSRP1 RFC5 LRPPRC PHF14 PRKCSH USP48 | 4.41e-10 | 394 | 185 | 16 | 27248496 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B TPR AARS1 RANGAP1 MYH10 TRA2B CALU EIF4A3 SYNE1 SMC1A SPTAN1 SPTBN1 PABPC4 RCN2 SMC4 MRPS35 SSRP1 RFC5 ACTR2 LRPPRC GUCY1B2 NAT10 SMARCE1 DLST PRKCSH CACYBP MYO18B PUM1 ADGRA3 | 5.75e-10 | 1425 | 185 | 29 | 30948266 |
| Pubmed | TPR RANGAP1 HIF1A MYH10 TRA2B UACA CALU EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 RCN2 SMC4 SPECC1L SSRP1 RFC5 ACTR2 PALS1 LRPPRC IGF2BP2 THOP1 AKAP9 NAT10 SMARCA2 CACYBP VCP | 6.39e-10 | 1247 | 185 | 27 | 27684187 | |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | MORC1 MYH10 MYL1 SPTAN1 SPTBN1 CEP290 PABPC4 SLFN12 EFHD2 SPECC1L ACTR2 KCTD17 POTEE LRPPRC DLST PLEC VCP | 6.74e-10 | 468 | 185 | 17 | 36042349 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | TPR KRT5 MYH10 CASP14 TRA2B STRBP EIF4A3 SMC1A SPTBN1 PABPC4 SSRP1 KNOP1 IGF2BP2 DDX46 NAT10 SMARCA2 SMARCE1 PHF14 HDGFL2 | 7.24e-10 | 605 | 185 | 19 | 28977666 |
| Pubmed | TRA2B STRBP EIF4A3 KMT5A SYNE1 SMC1A SPTAN1 SPTBN1 CYP27A1 SMC4 EFHD2 SSRP1 RFC5 TRIP11 SETD2 NAT10 SMARCE1 DMD CACYBP PUM1 MRTFA | 7.61e-10 | 754 | 185 | 21 | 35906200 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH10 CASP14 EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 SMC4 SPECC1L LRPPRC IGF2BP2 DST PRKCSH PLEC CACYBP VCP LRRFIP1 | 9.00e-10 | 477 | 185 | 17 | 31300519 |
| Pubmed | TPR RANGAP1 SPTAN1 SMC4 NAP1L4 EFHD2 NCK1 SPECC1L SSRP1 TAB3 PALS1 SETD2 DDX46 NAT10 SMARCE1 LRBA CACYBP LRRFIP1 | 1.06e-09 | 549 | 185 | 18 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR UIMC1 AARS1 RANGAP1 MYH10 ANK2 NAP1L4 TRIP11 PPP4R3A KNOP1 SETD2 IGF2BP2 DDX46 DST NAT10 SMARCE1 PPP1R9B LRBA CACYBP CAMSAP1 SMCR8 HDGFL2 VCP | 1.20e-09 | 934 | 185 | 23 | 33916271 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B TPR UIMC1 RANGAP1 DNAJC13 UACA SMC1A SPTAN1 SPTBN1 SSRP1 PPP4R3A WWC2 SETD2 DDX46 SLC4A1AP SMARCA2 PHF14 RIMS1 PLEC MRTFA LRRFIP1 | 1.21e-09 | 774 | 185 | 21 | 15302935 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT5 MYH10 ANKS6 HSP90B2P MYO5A MAP2 CALU SPTAN1 SPTBN1 CEP290 RCN2 NAP1L4 EFHD2 CKM KRT76 VCAN PLEC ENO3 | 1.62e-09 | 564 | 185 | 18 | 21565611 |
| Pubmed | TACO1 PDS5B TPR AARS1 EIF4A3 SPTAN1 CYP24A1 SPTBN1 PABPC4 MRPS35 SSRP1 POTEE LRPPRC IGF2BP2 DDX46 NAT10 DLST PLEC HDGFL2 VCP | 1.67e-09 | 711 | 185 | 20 | 33022573 | |
| Pubmed | UIMC1 FAM184A UACA MYO5A SYNE1 PABPC4 WRN MAP3K20 RCN2 SMC4 NAP1L4 MRPS35 EFHD2 SPECC1L SSRP1 RFC5 KNOP1 POTEE SETD2 DDX46 DST SLC4A1AP ZBED6 MACO1 SMARCA2 TMF1 SMARCE1 PHF14 HDGFL2 | 1.76e-09 | 1497 | 185 | 29 | 31527615 | |
| Pubmed | TPR AARS1 RANGAP1 SPTAN1 SPTBN1 MPZL1 NAP1L4 EFHD2 NCK1 TRIP11 GRAMD1B DST MACO1 TMF1 CCDC25 TYW1 LRBA CAMSAP1 | 1.80e-09 | 568 | 185 | 18 | 37774976 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | MYH1 RANGAP1 MYH10 SPTAN1 SPTBN1 PABPC4 DGKE IGF2BP2 ROCK1 MYOCD DMD STK38L HDGFL2 VCP | 1.93e-09 | 317 | 185 | 14 | 17620599 |
| Pubmed | KRT5 AARS1 MYH10 DNAJC13 CASP14 TRA2B MYO5A CALU EIF4A3 SYNE1 SMC1A PABPC4 SMC4 ACTR2 LRPPRC CASKIN1 DLST PRKCSH PLEC VCP MX2 | 2.32e-09 | 803 | 185 | 21 | 36517590 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | KRT5 MYH10 UACA MYO5A POTEF SPTAN1 SPTBN1 PABPC4 EFHD2 SPECC1L SSRP1 ACTR2 POTEE LRPPRC IGF2BP2 NAT10 DLST PLEC | 2.50e-09 | 580 | 185 | 18 | 35676659 |
| Pubmed | RANGAP1 MYH10 CLGN UACA CALU STRBP SPTAN1 SPTBN1 PABPC4 RCN2 SMC4 NAP1L4 MRPS35 DGKE SPECC1L SSRP1 RFC5 ACTR2 GRAMD1B LRPPRC IGF2BP2 DDX46 DST MACO1 NAT10 DLST VCP LRRFIP1 | 3.21e-09 | 1440 | 185 | 28 | 30833792 | |
| Pubmed | RANGAP1 DNAJC13 TRA2B SYNE1 NAP1L4 EFHD2 NCK1 TRIP11 RABGAP1L TMF1 LRBA CACYBP SMCR8 LRRFIP1 | 4.55e-09 | 339 | 185 | 14 | 37232246 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | PDS5B TPR KRT5 RANGAP1 MYH10 TRA2B EIF4A3 KMT5A SPTAN1 SPTBN1 PABPC4 RCN2 STK11IP PALS1 LRPPRC IGF2BP2 OSBPL1A PHF14 DLST CAMSAP1 PUM1 VCP | 5.00e-09 | 922 | 185 | 22 | 27609421 |
| Pubmed | TPR MYO5A SYNE1 DST OTOF FAM186A NAT10 DLST PLEC LRBA DMD CAMSAP1 | 5.43e-09 | 234 | 185 | 12 | 36243803 | |
| Pubmed | AARS1 ANK2 MYO5A EIF4A3 SYNE1 SMC1A SPTAN1 TTLL5 SPTBN1 CEP290 MRPS35 NCK1 JAKMIP3 TRIP11 THOP1 DST OTOF KRT222 OSBPL1A SMARCE1 DLST PLEC DNAI7 LRBA VCP LRRFIP1 | 5.56e-09 | 1285 | 185 | 26 | 35914814 | |
| Pubmed | KRT5 MYH4 MYH10 UACA SPTAN1 SPECC1L LRPPRC DST PRKCSH PLEC VCP | 7.20e-09 | 191 | 185 | 11 | 33762435 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPR KRT5 AARS1 RANGAP1 MYH10 EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 SMC4 NAP1L4 MRPS35 EFHD2 SSRP1 RFC5 RTF1 LRPPRC DDX46 THOP1 SLC4A1AP SMARCE1 PLEC CACYBP HDGFL2 VCP LRRFIP1 | 9.40e-09 | 1415 | 185 | 27 | 28515276 |
| Pubmed | TPR UIMC1 MYH10 CASP14 MYO5A PABPC4 SPECC1L SSRP1 TRIP11 ACTR2 LRPPRC DST NAT10 SMARCA2 SMARCE1 PPP1R9B AKT1 CACYBP | 9.92e-09 | 634 | 185 | 18 | 34591612 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PDS5B AARS1 MAP2 SPTBN1 SMC4 RFC5 RTF1 DDX46 SLC4A1AP CROCC2 ZNF408 DNAI7 LRBA PUM1 HDGFL2 GOLGA1 | 1.20e-08 | 497 | 185 | 16 | 36774506 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | KRT5 MYH4 MYH10 DNAJC13 UACA MYO5A WRN SMC4 SPECC1L SMARCA2 PLEC | 1.29e-08 | 202 | 185 | 11 | 33005030 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RANGAP1 DNAJC13 UACA MYO5A STRBP SPTAN1 PABPC4 EFHD2 SPECC1L ACTR2 IGF2BP2 NAT10 GKAP1 PPP1R9B PLEC CACYBP CAMSAP1 PUM1 LRRFIP1 | 1.33e-08 | 724 | 185 | 19 | 36232890 |
| Pubmed | TPR MYH10 POTEF SPTAN1 SPTBN1 RTF1 DDX46 DST SLC4A1AP SMARCE1 DLST POTEI HDGFL2 MRTFA VCP LRRFIP1 | 1.54e-08 | 506 | 185 | 16 | 30890647 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B TPR AARS1 RANGAP1 MYH10 DNAJC13 CASP14 TRA2B MYO5A EIF4A3 SMC1A SPTAN1 SPTBN1 MAP3K20 SMC4 SSRP1 RFC5 LRPPRC IGF2BP2 DST NAT10 SMARCA2 DLST PLEC PUM1 VCP | 1.58e-08 | 1353 | 185 | 26 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | AARS1 RANGAP1 MYH10 DNAJC13 CASP14 TRA2B CALU SPTBN1 SMC4 NAP1L4 EFHD2 SSRP1 RFC5 GSS LRPPRC IGF2BP2 DDX46 SMARCA2 ROCK1 SMARCE1 DLST PRKCSH CACYBP HDGFL2 VCP LRRFIP1 | 1.94e-08 | 1367 | 185 | 26 | 32687490 |
| Pubmed | TACO1 TPR RANGAP1 CASP14 MYO5A CALU EIF4A3 SMC1A SMC4 MRPS35 NCK1 CHN1 KNOP1 POTEE MACO1 SMARCE1 PPP1R9B PRKCSH PLEC DMD CACYBP | 2.27e-08 | 916 | 185 | 21 | 32203420 | |
| Pubmed | AARS1 MYH10 DNAJC13 UACA CALU SMC1A RCN2 EFHD2 SPECC1L SSRP1 KNOP1 LRPPRC IGF2BP2 NAT10 PLEC PUM1 HDGFL2 | 2.74e-08 | 601 | 185 | 17 | 33658012 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TACO1 KRT5 MYH10 TRA2B SYNE1 TTLL5 MRPS35 DGKE SSRP1 RFC5 TRIP11 RBM20 ACTR2 POTEE LRPPRC IGF2BP2 VPS52 DST AKAP9 MACO1 NAT10 CCDC25 DLST PRKCSH CACYBP SMCR8 VCP | 2.97e-08 | 1496 | 185 | 27 | 32877691 |
| Pubmed | TPR MYH10 DNAJC13 MYL1 TRA2B CALU SMC1A PABPC4 SMC4 SPECC1L SSRP1 RFC5 KNOP1 IGF2BP2 DDX46 NAT10 SMARCE1 DLST PUM1 VCP | 3.11e-08 | 847 | 185 | 20 | 35850772 | |
| Pubmed | 3.27e-08 | 60 | 185 | 7 | 20682791 | ||
| Pubmed | MYH1 MYH10 POTEF SMC1A SPTAN1 SPTBN1 SMC4 NAP1L4 ACTR2 LRPPRC DDX46 DST DMD MYO18B ENO3 HDGFL2 | 3.61e-08 | 538 | 185 | 16 | 28524877 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AARS1 TRA2B MAP2 CALU POTEF SPTAN1 SPTBN1 MAP3K20 SSRP1 TRIP11 TAB3 CCDC88C WWC2 LRPPRC DST AKAP9 RABGAP1L PLEC CAMSAP1 PUM1 | 4.06e-08 | 861 | 185 | 20 | 36931259 |
| Pubmed | RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma. | 4.13e-08 | 62 | 185 | 7 | 35568845 | |
| Pubmed | UIMC1 MYH10 CASP14 MYO5A CALU STRBP SMC1A SPTAN1 SPTBN1 PABPC4 RCN2 NAP1L4 MRPS35 GMEB2 RBM20 TAB3 ZNF771 PALS1 IGF2BP2 DST NAT10 SMARCA2 SMARCE1 PRKCSH CACYBP PUM1 | 4.70e-08 | 1429 | 185 | 26 | 35140242 | |
| Pubmed | KRT5 MYH10 DNAJC13 MYL1 TRA2B CALU STRBP EIF4A3 PABPC4 RCN2 SETD2 IGF2BP2 NAT10 TMF1 | 6.83e-08 | 421 | 185 | 14 | 34650049 | |
| Pubmed | TPR AARS1 MYH10 UACA EIF4A3 SMC1A SPTBN1 SMC4 NAP1L4 MRPS35 RFC5 LRPPRC NAT10 DLST PLEC DMD CACYBP VCP LRRFIP1 | 7.63e-08 | 809 | 185 | 19 | 32129710 | |
| Pubmed | PDS5B TPR RANGAP1 CASP14 EIF4A3 SMC1A SPTAN1 SPTBN1 SMC4 RFC5 ACTR2 POTEE LRPPRC NAT10 DLST PLEC VCP | 8.82e-08 | 652 | 185 | 17 | 31180492 | |
| Pubmed | B3GALNT1 TPR MYH10 MYL1 CASP14 SMC1A GSS LRPPRC SMARCA2 ROCK1 LRBA DMD | 9.72e-08 | 304 | 185 | 12 | 32235678 | |
| Pubmed | KRT5 MYH4 MYH10 MYO5A SPTAN1 SPTBN1 PABPC4 ACTR2 PPP1R9B PLEC POTEI LRRFIP1 | 1.01e-07 | 305 | 185 | 12 | 33194618 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | TPR KRT5 RANGAP1 MYH10 TRA2B MYO5A SMC1A PGK2 ACTR2 LRPPRC DDX46 NAT10 SMARCE1 DLST CACYBP ENO3 HDGFL2 | 1.17e-07 | 665 | 185 | 17 | 30457570 |
| Pubmed | AARS1 MYH10 DNAJC13 COL12A1 MYL1 TRA2B CALU STRBP EIF4A3 SPTAN1 PABPC4 MPZL1 RCN2 SMC4 STK11IP ACTR2 S100A2 CKM LRPPRC THOP1 DST PRKCSH CACYBP VCP | 1.19e-07 | 1297 | 185 | 24 | 33545068 | |
| Pubmed | 1.29e-07 | 151 | 185 | 9 | 17043677 | ||
| Pubmed | CTTNBP2 SMC1A SPTAN1 MAP3K20 RCN2 CCDC88C PALS1 IGF2BP2 DST AKAP9 PPP1R9B CACYBP PUM1 STK38L | 1.38e-07 | 446 | 185 | 14 | 24255178 | |
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 18753145 | ||
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 36515178 | ||
| Pubmed | 1.59e-07 | 10 | 185 | 4 | 19506036 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PDS5B MYH10 TRA2B EIF4A3 SMC1A PABPC4 WRN SMC4 MRPS35 SSRP1 GMEB2 RFC5 ACTR2 KNOP1 LRPPRC IGF2BP2 VPS52 DDX46 NAT10 SMARCA2 PLEC LRBA CACYBP PUM1 | 1.60e-07 | 1318 | 185 | 24 | 30463901 |
| Pubmed | Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. | 1.62e-07 | 155 | 185 | 9 | 22673621 | |
| Pubmed | AARS1 COL12A1 KMT5A CEP290 MRPS35 EFHD2 TUT1 GARIN3 AKAP9 SLC4A1AP CROCC2 ROCK1 CCDC25 DLST USP48 VCP LRRFIP1 | 1.92e-07 | 689 | 185 | 17 | 36543142 | |
| Pubmed | TDRD15 KRT5 DNAJC13 ANKS6 PABPC4 MPZL1 WRN SPECC1L TRIP11 RYR2 KNOP1 VPS52 DST ZBED6 TMF1 LRBA CAMSAP1 SMCR8 | 2.09e-07 | 777 | 185 | 18 | 35844135 | |
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | HIF1A MYH10 UACA MYO5A SPTAN1 SPTBN1 PABPC4 RCN2 EFHD2 SPECC1L PLEC STK38L | 2.20e-07 | 328 | 185 | 12 | 23398456 |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | TPR AARS1 FAM184A SPTBN1 PABPC4 PABPC4L JAKMIP3 LRPPRC IGF2BP2 KRT76 DST AKAP9 | 2.28e-07 | 329 | 185 | 12 | 34316702 |
| Pubmed | MYH1 MYH8 MYL2 SPTBN1 RYR2 CKM LRPPRC DDX46 DST DLST PLEC ENO3 | 2.43e-07 | 331 | 185 | 12 | 29199018 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | TACO1 TPR AARS1 FAM184A HSP90B2P TRA2B CALU RCN2 MRPS35 TRIP11 ACTR2 PPP4R3A LRPPRC IGF2BP2 THOP1 AKAP9 SLC4A1AP TRIM17 SMARCE1 DLST AKT1 PRKCSH PLEC GOLGA1 VCP | 2.43e-07 | 1451 | 185 | 25 | 30550785 |
| Pubmed | 2.46e-07 | 80 | 185 | 7 | 35803934 | ||
| Pubmed | 2.48e-07 | 11 | 185 | 4 | 8136524 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TPR UIMC1 AARS1 RANGAP1 SMC1A SPTAN1 SPTBN1 SMC4 RFC5 NAT10 PLEC USP48 | 2.51e-07 | 332 | 185 | 12 | 32786267 |
| Pubmed | PDS5B CASP14 SMC1A SPTAN1 SPTBN1 LRPPRC VPS52 NAT10 SMARCE1 PLEC STK38L | 2.65e-07 | 272 | 185 | 11 | 31010829 | |
| Pubmed | MYO5A SPTAN1 SPTBN1 EFHD2 SPECC1L SSRP1 PALS1 PPP1R9B PHF14 POTEI HDGFL2 LRRFIP1 | 2.67e-07 | 334 | 185 | 12 | 30425250 | |
| Pubmed | TPR KRT5 AARS1 MYH10 MYL1 EIF4A3 SPTBN1 PABPC4 SSRP1 ACTR2 LRPPRC IGF2BP2 NAT10 PLEC LRBA CACYBP VCP | 2.76e-07 | 707 | 185 | 17 | 19738201 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.78e-07 | 120 | 185 | 8 | 31413325 | |
| Pubmed | TPR RANGAP1 ANK2 SMC1A SPTBN1 PABPC4 RCN2 SMC4 NCK1 LRPPRC DST ROCK1 LRBA CACYBP CAMSAP1 SMCR8 VCP | 2.81e-07 | 708 | 185 | 17 | 39231216 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | AARS1 HSP90B2P CLGN SMC1A RCN2 SMC4 NAP1L4 MRPS35 EFHD2 NCK1 PPP4R3A WWC2 LRPPRC IGF2BP2 THOP1 MACO1 PRKCSH DMD CACYBP VCP | 2.92e-07 | 974 | 185 | 20 | 28675297 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | MYH10 EIF4A3 SMC1A SPTAN1 SPTBN1 RCN2 LRPPRC VCAN SMARCE1 PLEC | 3.09e-07 | 219 | 185 | 10 | 31353912 |
| Pubmed | AARS1 MYH10 HSP90B2P CALB2 MYO5A MAP2 SPTAN1 SPTBN1 EFHD2 ACTR2 SYT1 DMD USP48 ENO3 VCP | 3.10e-07 | 552 | 185 | 15 | 36293380 | |
| Pubmed | MYH10 A1CF ANK2 UACA STRBP SPTAN1 SPTBN1 PABPC4 WRN MAP3K20 RCN2 SPECC1L SSRP1 KNOP1 IGF2BP2 DDX46 AKAP9 NAT10 SMARCE1 DLST PLEC VCP MX2 LRRFIP1 | 3.26e-07 | 1371 | 185 | 24 | 36244648 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | AARS1 MYH10 MYL2 EIF4A3 SYNE1 SPTAN1 SPTBN1 ACTR2 LRPPRC THOP1 DST AKAP9 MYOCD PRKCSH PLEC LRBA CACYBP VCP | 3.63e-07 | 807 | 185 | 18 | 30575818 |
| Interaction | LATS1 interactions | MYH1 KRT5 MYH4 MYH8 MYL1 SPTAN1 SPTBN1 CEP290 RCN2 STK31 TRIP11 TAB3 S100A2 CKM CCDC88C PALS1 WWC2 AKAP9 PLEC PUM1 ENO3 | 6.14e-10 | 440 | 183 | 21 | int:LATS1 |
| Interaction | DCTN1 interactions | TPR KRT5 RANGAP1 MAP2 SPTBN1 CEP290 SMC4 NAP1L4 SPECC1L PPP4R3A CCDC88C IGF2BP2 KRT76 DST GKAP1 PPP1R9B AKT1 PRKCSH CAMSAP1 USP48 ENO3 LRRFIP1 | 9.56e-10 | 497 | 183 | 22 | int:DCTN1 |
| Interaction | TNIP1 interactions | TPR UIMC1 AARS1 RANGAP1 MYH10 MYL1 CASP14 TRA2B UACA MYO5A EIF4A3 POTEF SYNE1 SMC1A SPTAN1 SPTBN1 PABPC4 MAP3K20 SMC4 EFHD2 SPECC1L SSRP1 PGK2 ACTR2 LRPPRC DDX46 DST NAT10 PPP1R9B PLEC DMD ADGRA3 VCP LRRFIP1 | 3.91e-09 | 1217 | 183 | 34 | int:TNIP1 |
| Interaction | YAP1 interactions | TPR RANGAP1 HIF1A MYH10 UACA MAP2 POTEF SPTAN1 SPTBN1 SMC4 NAP1L4 EFHD2 NCK1 SSRP1 TAB3 RTF1 POTEE PALS1 WWC2 SETD2 KRT76 DDX46 NAT10 SMARCA2 SMARCE1 CCDC25 AKT1 PLEC POTEI CACYBP ENO3 VCP | 4.13e-09 | 1095 | 183 | 32 | int:YAP1 |
| Interaction | ACTC1 interactions | TPR MYH10 EIF4A3 POTEF SYNE1 SPTAN1 SPTBN1 ACTR2 RTF1 POTEE DDX46 DST SLC4A1AP SMARCA2 SMARCE1 PPP1R9B DLST PLEC DMD POTEI USP48 HDGFL2 MRTFA VCP LRRFIP1 | 4.36e-09 | 694 | 183 | 25 | int:ACTC1 |
| Interaction | CYLD interactions | KRT5 RANGAP1 FAM184A MYH10 DNAJC13 MYL1 CASP14 TRA2B UACA KMT5A SPTAN1 SPTBN1 PABPC4 RCN2 RFC5 TAB3 KCTD17 IGF2BP2 MICU3 SLC4A1AP ROCK1 DLST AKT1 PLEC CACYBP STK38L ENO3 VCP | 5.32e-09 | 868 | 183 | 28 | int:CYLD |
| Interaction | ACTA1 interactions | HIF1A MYL1 PAGE4 POTEF SPTAN1 ACTR2 S100A1 S100A2 CKM POTEE DST PPP1R9B AKT1 PLEC DMD POTEI ENO3 VCP | 8.60e-09 | 371 | 183 | 18 | int:ACTA1 |
| Interaction | NUPR1 interactions | PDS5B TPR RANGAP1 MYH10 TRA2B UACA MYO5A EIF4A3 SPTAN1 SPTBN1 EFHD2 SPECC1L RFC5 ACTR2 POTEE DDX46 DST NAT10 PPP1R9B DLST PLEC HDGFL2 VCP LRRFIP1 | 1.47e-08 | 683 | 183 | 24 | int:NUPR1 |
| Interaction | MECOM interactions | TPR MYH1 MYH4 MYH8 MYL1 CALU SMC1A RCN2 SMC4 SSRP1 ACTR2 CKM RABGAP1L NAT10 SMARCE1 PPP1R9B PLEC | 3.12e-08 | 358 | 183 | 17 | int:MECOM |
| Interaction | CHMP4C interactions | AARS1 MYH10 CASP14 TRA2B CALU STRBP EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 RCN2 NAP1L4 EFHD2 SPECC1L SSRP1 ACTR2 LRPPRC NAT10 CCDC25 PRKCSH CACYBP VCP | 7.28e-08 | 687 | 183 | 23 | int:CHMP4C |
| Interaction | BAP1 interactions | TPR KRT5 AARS1 RANGAP1 HIF1A MYH10 TRA2B MYO5A CALU SMC1A SPTAN1 SPTBN1 PABPC4 RCN2 SMC4 NAP1L4 MRPS35 EFHD2 SSRP1 ACTR2 GSS PALS1 LRPPRC IGF2BP2 DDX46 DST AKT1 PRKCSH PLEC CACYBP STK38L HDGFL2 VCP | 8.81e-08 | 1314 | 183 | 33 | int:BAP1 |
| Interaction | PRC1 interactions | PDS5B TPR AARS1 RANGAP1 MYH10 TRA2B STRBP EIF4A3 SYNE1 SPTAN1 SPTBN1 PABPC4 SMC4 NAP1L4 SPECC1L SSRP1 RFC5 GRAMD1B LRPPRC IGF2BP2 DDX46 AKAP9 ZNF408 NAT10 PHF14 PLEC VCP | 2.23e-07 | 973 | 183 | 27 | int:PRC1 |
| Interaction | GLDC interactions | RANGAP1 MYH10 UACA STRBP SPTAN1 SPTBN1 PABPC4 SPECC1L PALS1 LRPPRC NAT10 PPP1R9B PLEC PUM1 VCP | 2.57e-07 | 321 | 183 | 15 | int:GLDC |
| Interaction | RGS14 interactions | AARS1 MYH10 CALB2 ANK2 MYO5A SPTAN1 SPTBN1 NAP1L4 ACTR2 CASKIN1 SYT1 PPP1R9B LRRFIP1 | 3.14e-07 | 240 | 183 | 13 | int:RGS14 |
| Interaction | WDR76 interactions | RANGAP1 MYH10 EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 RCN2 SMC4 SSRP1 S100A2 LRPPRC VCAN SMARCE1 PLEC USP48 | 4.56e-07 | 383 | 183 | 16 | int:WDR76 |
| Interaction | RCOR1 interactions | TPR MYH10 DNAJC13 SPTAN1 SMC4 RBM20 PPP4R3A DDX46 DST RABGAP1L TMF1 SMARCE1 PLEC LRBA CAMSAP1 MRTFA VCP LRRFIP1 | 6.29e-07 | 494 | 183 | 18 | int:RCOR1 |
| Interaction | OBSL1 interactions | PDS5B TPR KRT5 RANGAP1 DNAJC13 MYL1 TRA2B MAP2 CALU STRBP EIF4A3 SYNE1 SMC1A MRPS35 SSRP1 RFC5 ACTR2 PPP4R3A POTEE DDX46 DST CROCC2 NAT10 PLEC VCP | 6.72e-07 | 902 | 183 | 25 | int:OBSL1 |
| Interaction | KIF20A interactions | PDS5B MYH10 ANK2 TRA2B UACA EIF4A3 SYNE1 SPTAN1 SPTBN1 PABPC4 NAP1L4 SPECC1L SSRP1 TRIP11 S100A2 POTEE LRPPRC IGF2BP2 DDX46 ZNF408 RABGAP1L NAT10 SMARCA2 PPP1R9B CCDC25 PLEC VCP | 1.02e-06 | 1052 | 183 | 27 | int:KIF20A |
| Interaction | BTF3 interactions | KRT5 MYH10 MYL1 ANK2 TRA2B UACA MYO5A CALU SPTAN1 SPTBN1 PABPC4 RCN2 NAP1L4 EFHD2 SPECC1L SSRP1 RFC5 ACTR2 LRPPRC IGF2BP2 DLST PLEC VCP | 1.03e-06 | 799 | 183 | 23 | int:BTF3 |
| Interaction | CFTR interactions | PDS5B TPR MYH1 KRT5 MYH4 AARS1 MYH8 MYH10 CASP14 CALU STRBP ZBED2 SPTAN1 SPTBN1 PABPC4 RCN2 SMC4 ARMC9 SPECC1L RFC5 ACTR2 RYR2 LRPPRC IGF2BP2 DLST PRKCSH PLEC LRBA DMD PUM1 VCP MX2 TGS1 | 1.31e-06 | 1480 | 183 | 33 | int:CFTR |
| Interaction | STIP1 interactions | TPR RANGAP1 MYH10 DNAJC13 TRA2B EIF4A3 SMC1A SPTAN1 SPTBN1 RCN2 SMC4 NAP1L4 SSRP1 ACTR2 PPP4R3A LRPPRC DDX46 NAT10 PPP1R9B PLEC LRBA CACYBP PUM1 USP48 ENO3 VCP | 1.46e-06 | 1006 | 183 | 26 | int:STIP1 |
| Interaction | FBXW7 interactions | AARS1 HIF1A MYH10 DNAJC13 COL12A1 TRA2B UACA MYO5A CALU EIF4A3 SMC1A SPTBN1 RCN2 EFHD2 SPECC1L SSRP1 RFC5 ACTR2 KCTD17 KNOP1 LRPPRC IGF2BP2 NAT10 AKT1 PLEC PUM1 HDGFL2 VCP TGS1 | 1.67e-06 | 1215 | 183 | 29 | int:FBXW7 |
| Interaction | MECP2 interactions | TACO1 PDS5B KRT5 RANGAP1 MYH10 DNAJC13 TRA2B MAP2 EIF4A3 SYNE1 SMC1A SPTAN1 SPTBN1 RCN2 NAP1L4 SSRP1 KNOP1 LRPPRC SETD2 IGF2BP2 DDX46 DST VCAN NAT10 SMARCA2 SMARCE1 PHF14 DLST PLEC VCP | 1.75e-06 | 1287 | 183 | 30 | int:MECP2 |
| Interaction | IQGAP1 interactions | MYH1 HIF1A MYH10 MYL1 MYO5A EIF4A3 SPTAN1 SPTBN1 SPECC1L ACTR2 S100A2 LRPPRC DST PPP1R9B DLST AKT1 PLEC VCP LRRFIP1 | 1.96e-06 | 591 | 183 | 19 | int:IQGAP1 |
| Interaction | PCNT interactions | FAM184A SYNE1 SPTAN1 SPTBN1 CEP290 NAP1L4 TRIP11 S100A2 DST AKAP9 PLEC GOLGA1 | 2.19e-06 | 241 | 183 | 12 | int:PCNT |
| Interaction | TNIK interactions | TPR IQSEC3 CTTNBP2 ANK2 MYO5A SYNE1 SPTAN1 SPTBN1 NCK1 PALS1 DST AKAP9 NAT10 SMARCE1 RIMS1 | 2.20e-06 | 381 | 183 | 15 | int:TNIK |
| Interaction | EEF2K interactions | 2.25e-06 | 66 | 183 | 7 | int:EEF2K | |
| Interaction | MYH6 interactions | 2.27e-06 | 94 | 183 | 8 | int:MYH6 | |
| Interaction | CIT interactions | PDS5B TPR AARS1 RANGAP1 MYH10 HSP90B2P CLGN TRA2B CALU STRBP EIF4A3 SYNE1 SMC1A SPTAN1 SPTBN1 PABPC4 RCN2 SMC4 SPECC1L SSRP1 RFC5 ACTR2 LRPPRC IGF2BP2 DDX46 AKAP9 ZNF408 NAT10 SMARCA2 CCDC25 PLEC HDGFL2 | 2.42e-06 | 1450 | 183 | 32 | int:CIT |
| Interaction | FBXO32 interactions | MYH1 MYH4 MYH8 MYL1 RCN2 SMC4 MRPS35 CKM THOP1 MYOCD PRKCSH PLEC USP48 ENO3 VCP | 2.59e-06 | 386 | 183 | 15 | int:FBXO32 |
| Interaction | YWHAG interactions | AARS1 MYH10 PAGE4 TRA2B UACA MAP2 POTEF SPTAN1 SPTBN1 PABPC4 MAP3K20 SPECC1L TRIP11 ACTR2 TAB3 GSS CCDC88C WWC2 DST AKAP9 RABGAP1L PPP1R9B DLST AKT1 LRBA CAMSAP1 PUM1 USP48 VCP | 2.85e-06 | 1248 | 183 | 29 | int:YWHAG |
| Interaction | LRRC31 interactions | KRT5 MYH4 MYH10 DNAJC13 UACA MYO5A WRN SMC4 SPECC1L SMARCA2 PLEC | 2.86e-06 | 205 | 183 | 11 | int:LRRC31 |
| Interaction | FGD5 interactions | KRT5 MYH4 MYH10 UACA SPTAN1 SPECC1L LRPPRC DST PRKCSH PLEC VCP | 3.14e-06 | 207 | 183 | 11 | int:FGD5 |
| Interaction | ABTB2 interactions | 3.90e-06 | 101 | 183 | 8 | int:ABTB2 | |
| Interaction | PINK1 interactions | MYH10 CASP14 EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 SMC4 PM20D1 SPECC1L S100A2 LRPPRC IGF2BP2 DST AKT1 PRKCSH PLEC CACYBP VCP LRRFIP1 | 3.91e-06 | 679 | 183 | 20 | int:PINK1 |
| Interaction | PFN1 interactions | TPR DNAJC13 ANK2 MYO5A SPTAN1 SPTBN1 NCK1 TRIP11 ACTR2 AKAP9 RABGAP1L TMF1 DLST PRKCSH USP48 MRTFA VCP | 4.22e-06 | 509 | 183 | 17 | int:PFN1 |
| Interaction | MYO18A interactions | RANGAP1 MYO5A SPTAN1 SPTBN1 EFHD2 SPECC1L ACTR2 DDX46 DST DLST PRKCSH PLEC USP48 | 4.24e-06 | 303 | 183 | 13 | int:MYO18A |
| Interaction | SIRT7 interactions | PDS5B TPR AARS1 RANGAP1 MYH10 MYO5A STRBP SPTAN1 SPTBN1 PABPC4 SMC4 ACTR2 LRPPRC IGF2BP2 DDX46 DST NAT10 SMARCA2 PLEC PUM1 VCP | 4.28e-06 | 744 | 183 | 21 | int:SIRT7 |
| Interaction | H2BC3 interactions | PDS5B EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 NAP1L4 SSRP1 RFC5 KNOP1 LRPPRC PHF14 AKT1 PRKCSH USP48 | 4.78e-06 | 406 | 183 | 15 | int:H2BC3 |
| Interaction | CLEC4D interactions | AARS1 MYH10 CLGN MYO5A CALU SPTAN1 TNFRSF10B SSRP1 TRIP11 ACTR2 IGF2BP2 PPP1R9B | 4.97e-06 | 261 | 183 | 12 | int:CLEC4D |
| Interaction | RAB25 interactions | RANGAP1 SYNE1 NAP1L4 EFHD2 NCK1 TRIP11 RABGAP1L TMF1 LRBA CACYBP SMCR8 LRRFIP1 | 5.80e-06 | 265 | 183 | 12 | int:RAB25 |
| Interaction | MYCN interactions | PDS5B TPR KRT5 MYH10 CASP14 TRA2B MAP2 CALU STRBP EIF4A3 SYNE1 PABPC4 RCN2 SMC4 MRPS35 CHGB SSRP1 KNOP1 ZNF771 LRPPRC SETD2 IGF2BP2 VPS52 DDX46 NAT10 SMARCA2 SMARCE1 POTEI CACYBP HDGFL2 | 6.41e-06 | 1373 | 183 | 30 | int:MYCN |
| Interaction | RAB11A interactions | TPR RANGAP1 MYH10 DNAJC13 MYO5A CALU SPTAN1 SPTBN1 NAP1L4 EFHD2 NCK1 TRIP11 S100A2 DST MACO1 RABGAP1L NAT10 TMF1 LRBA SMCR8 VCP LRRFIP1 | 6.79e-06 | 830 | 183 | 22 | int:RAB11A |
| Interaction | YWHAH interactions | UACA MAP2 POTEF SPTAN1 SPTBN1 CEP290 MAP3K20 SPECC1L SSRP1 TRIP11 ACTR2 TAB3 GSS CCDC88C WWC2 DST AKAP9 RABGAP1L PPP1R9B RIMS1 PLEC LRBA CAMSAP1 PUM1 USP48 VCP | 7.57e-06 | 1102 | 183 | 26 | int:YWHAH |
| Interaction | SUMO2 interactions | TPR UIMC1 KRT5 AARS1 RANGAP1 SMC1A SPTAN1 SPTBN1 WRN SMC4 SSRP1 RFC5 DST NAT10 PRKCSH PLEC USP48 VCP | 7.79e-06 | 591 | 183 | 18 | int:SUMO2 |
| Interaction | YWHAZ interactions | MYH10 TRA2B UACA MYO5A MAP2 POTEF SMC1A SPTAN1 SPTBN1 PABPC4 MAP3K20 ACTR2 TAB3 GRAMD1B CCDC88C WWC2 LRPPRC DST AKAP9 MACO1 PPP1R9B DLST AKT1 PLEC CAMSAP1 PUM1 CENATAC USP48 VCP | 8.30e-06 | 1319 | 183 | 29 | int:YWHAZ |
| Interaction | HDAC1 interactions | TPR MYH1 MYH4 MYH8 HIF1A MYH10 DNAJC13 SMC1A SPTAN1 WRN RCN2 SMC4 RBM20 PPP4R3A LRPPRC DST AKAP9 SMARCA2 TMF1 SMARCE1 PHF14 PLEC LRBA CAMSAP1 MRTFA LRRFIP1 | 8.34e-06 | 1108 | 183 | 26 | int:HDAC1 |
| Interaction | KCTD13 interactions | KRT5 IQSEC3 MYH10 DNAJC13 CTTNBP2 ANK2 MYO5A MAP2 SYNE1 SPTAN1 SPTBN1 PABPC4 EFHD2 SPECC1L TRIP11 ACTR2 GRAMD1B LRPPRC DST CASKIN1 VCAN GKAP1 SYT1 PPP1R9B DLST RIMS1 PLEC DMD VCP LRRFIP1 | 8.62e-06 | 1394 | 183 | 30 | int:KCTD13 |
| Interaction | NAA40 interactions | TPR UIMC1 AARS1 RANGAP1 MYH10 ANK2 NAP1L4 SSRP1 TRIP11 PPP4R3A KNOP1 SETD2 IGF2BP2 DDX46 DST NAT10 SMARCE1 PPP1R9B LRBA CACYBP CAMSAP1 SMCR8 HDGFL2 VCP | 9.21e-06 | 978 | 183 | 24 | int:NAA40 |
| Interaction | YWHAE interactions | MYH10 PAGE4 TRA2B EIF4A3 POTEF SPTAN1 PABPC4 MAP3K20 RCN2 EFHD2 TRIP11 ACTR2 TAB3 GSS CCDC88C WWC2 DST AKAP9 ROCK1 PPP1R9B DLST AKT1 LRBA CAMSAP1 PUM1 STK38L USP48 VCP | 9.40e-06 | 1256 | 183 | 28 | int:YWHAE |
| Interaction | YWHAQ interactions | TPR UACA MAP2 CALU EIF4A3 POTEF PABPC4 MAP3K20 TUT1 SPECC1L TRIP11 ACTR2 TAB3 CKM CCDC88C WWC2 LRPPRC DST MACO1 DLST PLEC LRBA CAMSAP1 PUM1 USP48 VCP | 9.76e-06 | 1118 | 183 | 26 | int:YWHAQ |
| Interaction | ADARB1 interactions | TPR ANK2 STRBP POTEF SMC1A PABPC4 WRN SSRP1 KNOP1 ZNF771 LRPPRC DDX46 NAT10 PHF14 PLEC POTEI | 1.06e-05 | 489 | 183 | 16 | int:ADARB1 |
| Interaction | CHD4 interactions | TPR KRT5 HIF1A MYH10 CASP14 TRA2B STRBP EIF4A3 SMC1A SPTAN1 PABPC4 SMC4 SSRP1 PPP4R3A KNOP1 DDX46 NAT10 SMARCA2 SMARCE1 PHF14 PRKCSH HDGFL2 LRRFIP1 | 1.46e-05 | 938 | 183 | 23 | int:CHD4 |
| Interaction | CALM3 interactions | ANKS6 MYL1 SPTAN1 SPTBN1 CEP290 SPECC1L ACTR2 PALS1 LRPPRC AKAP9 PPP1R9B DLST USP48 | 1.60e-05 | 343 | 183 | 13 | int:CALM3 |
| Interaction | CEBPB interactions | TPR AARS1 RANGAP1 TRA2B CALU EIF4A3 SMC1A PABPC4 RCN2 SMC4 EFHD2 SSRP1 ACTR2 RTF1 S100A2 LRPPRC IGF2BP2 DDX46 THOP1 AKAP9 NAT10 SMARCA2 TMF1 SMARCE1 PHF14 DLST PRKCSH PLEC CACYBP HDGFL2 | 1.68e-05 | 1443 | 183 | 30 | int:CEBPB |
| Interaction | MYH9 interactions | MYH10 PAGE4 UACA MYO5A EIF4A3 SPTAN1 SPTBN1 SMC4 EFHD2 SPECC1L ACTR2 LRPPRC DST PPP1R9B AKT1 PLEC STK38L USP48 VCP LRRFIP1 | 1.81e-05 | 754 | 183 | 20 | int:MYH9 |
| Interaction | SFN interactions | AARS1 HIF1A CASP14 MAP2 SPTAN1 SPTBN1 MAP3K20 TRIP11 TAB3 CCDC88C WWC2 DST AKAP9 RABGAP1L AKT1 PLEC CAMSAP1 PUM1 VCP | 1.85e-05 | 692 | 183 | 19 | int:SFN |
| Interaction | MAPRE1 interactions | RANGAP1 MAP2 EIF4A3 SPTAN1 SPTBN1 CEP290 PABPC4 SPECC1L ACTR2 DST AKAP9 SMARCE1 PPP1R9B PLEC CAMSAP1 GOLGA1 | 1.95e-05 | 514 | 183 | 16 | int:MAPRE1 |
| Interaction | ACTG1 interactions | TPR POTEF SPTAN1 SPTBN1 SPECC1L ACTR2 POTEE DST SMARCA2 SMARCE1 PPP1R9B PLEC POTEI MRTFA VCP LRRFIP1 | 2.25e-05 | 520 | 183 | 16 | int:ACTG1 |
| Interaction | MYCBP2 interactions | TPR IQSEC3 RANGAP1 ANK2 UACA SPTAN1 SPTBN1 EFHD2 SPECC1L DST PPP1R9B VCP LRRFIP1 | 2.30e-05 | 355 | 183 | 13 | int:MYCBP2 |
| Interaction | PPM1B interactions | AARS1 PAGE4 EIF4A3 SPTAN1 SPTBN1 PABPC4 SSRP1 S100A2 CACYBP VCP | 2.93e-05 | 216 | 183 | 10 | int:PPM1B |
| Interaction | HEXIM1 interactions | KRT5 HIF1A EIF4A3 POTEF PABPC4 SMC4 NAP1L4 MRPS35 SSRP1 RFC5 POTEE LRPPRC IGF2BP2 KRT76 RABGAP1L KRT222 OSBPL1A SMARCE1 POTEI STK38L ENO3 VCP | 2.95e-05 | 913 | 183 | 22 | int:HEXIM1 |
| Interaction | CCDC8 interactions | TPR KRT5 CASP14 TRA2B MYO5A SMC1A CEP290 PABPC4 MPZL1 SMC4 SPECC1L RFC5 LRPPRC IGF2BP2 DST PLEC PUM1 VCP | 3.13e-05 | 656 | 183 | 18 | int:CCDC8 |
| Interaction | FBXO22 interactions | PDS5B AARS1 MAP2 SPTBN1 SMC4 RFC5 RTF1 DDX46 SLC4A1AP CROCC2 ZNF408 DNAI7 LRBA PUM1 HDGFL2 GOLGA1 | 3.54e-05 | 540 | 183 | 16 | int:FBXO22 |
| Interaction | PRMT1 interactions | PDS5B TPR AARS1 MYH10 EIF4A3 SPTAN1 SPTBN1 PABPC4 SMC4 TAB3 CCDC88C LRPPRC IGF2BP2 SLC4A1AP NAT10 ROCK1 DLST PLEC PUM1 STK38L VCP LRRFIP1 | 3.83e-05 | 929 | 183 | 22 | int:PRMT1 |
| Interaction | HDAC6 interactions | KRT5 HIF1A MYH10 UACA MYO5A KMT5A POTEF SPTAN1 SPTBN1 PABPC4 EFHD2 SPECC1L SSRP1 ACTR2 POTEE LRPPRC IGF2BP2 NAT10 DLST AKT1 PLEC VCP | 3.83e-05 | 929 | 183 | 22 | int:HDAC6 |
| Interaction | DISC1 interactions | RANGAP1 EIF4A3 SYNE1 SPTAN1 SPTBN1 CEP290 SPECC1L TRIP11 KCTD17 DST AKAP9 SMARCE1 DMD ZSCAN23 | 3.95e-05 | 429 | 183 | 14 | int:DISC1 |
| Interaction | USP15 interactions | MYH4 MYH10 CTTNBP2 PAGE4 SMC1A SMC4 TUT1 TAB3 PPP4R3A LRPPRC TRIM17 PRKCSH RIMS1 CACYBP VCP LRRFIP1 | 4.04e-05 | 546 | 183 | 16 | int:USP15 |
| Interaction | RNF38 interactions | 4.05e-05 | 102 | 183 | 7 | int:RNF38 | |
| Interaction | HOMER1 interactions | 4.27e-05 | 140 | 183 | 8 | int:HOMER1 | |
| Interaction | ACTR1A interactions | MYH10 SPTBN1 SMC4 PPP4R3A PPP1R9B PRKCSH PLEC CACYBP USP48 VCP LRRFIP1 | 4.34e-05 | 274 | 183 | 11 | int:ACTR1A |
| Interaction | KCNA3 interactions | TPR RANGAP1 ANK2 SMC1A SPTBN1 PABPC4 AKNAD1 RCN2 SMC4 NCK1 SPECC1L CCDC88C LRPPRC DST ROCK1 RIMS1 LRBA CACYBP CAMSAP1 SMCR8 VCP | 4.50e-05 | 871 | 183 | 21 | int:KCNA3 |
| Interaction | EED interactions | PDS5B TPR AARS1 RANGAP1 MYH10 TRA2B STRBP EIF4A3 KMT5A SMC1A SPTAN1 SPTBN1 CEP290 SMC4 EFHD2 SSRP1 RFC5 ACTR2 LRPPRC IGF2BP2 THOP1 NAT10 SMARCA2 PPP1R9B PLEC CACYBP USP48 VCP TGS1 | 4.50e-05 | 1445 | 183 | 29 | int:EED |
| Interaction | LINC01554 interactions | 4.72e-05 | 142 | 183 | 8 | int:LINC01554 | |
| Interaction | ACTB interactions | MYH10 CTTNBP2 MAP2 EIF4A3 POTEF SPTAN1 SPTBN1 PABPC4 ACTR2 POTEE IGF2BP2 DST SMARCA2 SMARCE1 PPP1R9B CCDC25 AKT1 PLEC POTEI MYO18B USP48 MRTFA VCP LRRFIP1 | 4.80e-05 | 1083 | 183 | 24 | int:ACTB |
| Interaction | RND2 interactions | PDS5B TRA2B SPTAN1 SPTBN1 TNFRSF10B SSRP1 STK11IP TRIP11 DST MACO1 LRBA CACYBP SMCR8 VCP | 5.19e-05 | 440 | 183 | 14 | int:RND2 |
| Interaction | KRT8 interactions | MYH1 KRT5 UACA IFT57 TTLL5 TRIP11 KRT76 AKAP9 PPP1R9B PLEC DMD CAMSAP1 PUM1 VCP | 5.31e-05 | 441 | 183 | 14 | int:KRT8 |
| Interaction | HERC2 interactions | MYH10 HSP90B2P ANK2 EIF4A3 SPTBN1 CEP290 PABPC4 WRN SPECC1L KNOP1 DDX46 DST AKAP9 NAT10 PLEC | 5.82e-05 | 503 | 183 | 15 | int:HERC2 |
| Interaction | PARP1 interactions | MORC1 PDS5B UIMC1 RANGAP1 HIF1A MYH10 PAGE4 TRA2B STRBP SMC1A WRN SMC4 NCK1 SSRP1 RFC5 ACTR2 KNOP1 RTF1 NAT10 SMARCA2 ROCK1 SMARCE1 PHF14 CACYBP USP48 HDGFL2 VCP | 5.87e-05 | 1316 | 183 | 27 | int:PARP1 |
| Interaction | AURKAIP1 interactions | TACO1 MYH10 STRBP SMC1A NAP1L4 MRPS35 KNOP1 LRPPRC NAT10 DLST HDGFL2 | 6.00e-05 | 284 | 183 | 11 | int:AURKAIP1 |
| Interaction | H2BC9 interactions | PDS5B HIF1A MYH10 EIF4A3 SMC1A SPTAN1 CEP290 SPECC1L SSRP1 CCDC88C DST GUCY1B2 OTOF HDGFL2 | 6.00e-05 | 446 | 183 | 14 | int:H2BC9 |
| Interaction | CEBPA interactions | PDS5B AARS1 HIF1A TRA2B CALU EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 SMC4 NAP1L4 SSRP1 GMEB2 RFC5 ACTR2 PPP4R3A IGF2BP2 AKAP9 NAT10 SMARCA2 RPUSD2 SMARCE1 CACYBP HDGFL2 VCP | 6.11e-05 | 1245 | 183 | 26 | int:CEBPA |
| Interaction | NPHP4 interactions | 6.19e-05 | 236 | 183 | 10 | int:NPHP4 | |
| Interaction | H2AC4 interactions | PDS5B RANGAP1 MYH10 STRBP SPTAN1 SPTBN1 PABPC4 NAP1L4 SSRP1 RFC5 ACTR2 LRPPRC PHF14 DLST USP48 | 6.23e-05 | 506 | 183 | 15 | int:H2AC4 |
| Interaction | CHD3 interactions | TPR KRT5 MYH10 CASP14 TRA2B STRBP EIF4A3 SMC1A SPTBN1 PABPC4 SSRP1 GADD45A KNOP1 IGF2BP2 DDX46 NAT10 SMARCA2 SMARCE1 PHF14 | 6.24e-05 | 757 | 183 | 19 | int:CHD3 |
| Interaction | ADAR interactions | PAGE4 STRBP POTEF SMC1A SPTBN1 WRN SSRP1 KNOP1 S100A2 POTEE POTEI | 6.38e-05 | 286 | 183 | 11 | int:ADAR |
| Interaction | SUMO1 interactions | UIMC1 RANGAP1 HIF1A WRN SSRP1 DDX46 AKAP9 GOLGA1 FAM118B MRTFA VCP | 6.59e-05 | 287 | 183 | 11 | int:SUMO1 |
| Interaction | MIR199A2 interactions | 6.67e-05 | 76 | 183 | 6 | int:MIR199A2 | |
| Interaction | SYNPO interactions | 6.70e-05 | 192 | 183 | 9 | int:SYNPO | |
| Interaction | KRT14 interactions | 6.70e-05 | 192 | 183 | 9 | int:KRT14 | |
| Interaction | TERF2 interactions | MYH10 SYNE1 PABPC4 WRN SSRP1 RYR2 KCTD17 POTEE DST DMD HDGFL2 VCP | 6.78e-05 | 340 | 183 | 12 | int:TERF2 |
| Interaction | ATXN1 interactions | TPR KRT5 RANGAP1 MYH10 TRA2B MYO5A SMC1A GMEB2 STK31 ACTR2 LRPPRC SETD2 DDX46 NAT10 SMARCE1 DLST AKT1 CACYBP PUM1 USP48 ENO3 HDGFL2 VCP | 7.10e-05 | 1039 | 183 | 23 | int:ATXN1 |
| Interaction | MIR200A interactions | 7.18e-05 | 77 | 183 | 6 | int:MIR200A | |
| Interaction | TRIM31 interactions | KRT5 MYH10 DNAJC13 MYL1 TRA2B CALU STRBP EIF4A3 PABPC4 RCN2 SETD2 IGF2BP2 NAT10 TMF1 | 7.25e-05 | 454 | 183 | 14 | int:TRIM31 |
| Interaction | MIR98 interactions | 7.72e-05 | 78 | 183 | 6 | int:MIR98 | |
| Interaction | RAB4A interactions | DNAJC13 TRA2B MYO5A SYNE1 SPTAN1 TRIP11 VPS52 DST MACO1 RABGAP1L TMF1 ROCK1 LRBA SMCR8 | 7.77e-05 | 457 | 183 | 14 | int:RAB4A |
| Interaction | ACTG2 interactions | 8.06e-05 | 49 | 183 | 5 | int:ACTG2 | |
| Interaction | SSH1 interactions | 8.29e-05 | 79 | 183 | 6 | int:SSH1 | |
| Interaction | SOX2 interactions | KRT5 RANGAP1 DNAJC13 TRA2B EIF4A3 SMC1A SPTAN1 SPTBN1 PABPC4 WRN NAP1L4 MRPS35 PABPC4L EFHD2 TUT1 SPECC1L SSRP1 RFC5 SETD2 IGF2BP2 CROCC2 MACO1 NAT10 SMARCA2 SMARCE1 PPP1R9B DLST AKT1 | 8.60e-05 | 1422 | 183 | 28 | int:SOX2 |
| Interaction | FLII interactions | HIF1A MYH10 EIF4A3 SMC4 PPP4R3A LRPPRC DLST AKT1 PRKCSH VCP LRRFIP1 | 9.21e-05 | 298 | 183 | 11 | int:FLII |
| Cytoband | 18q11.1 | 9.64e-05 | 4 | 185 | 2 | 18q11.1 | |
| Cytoband | 6q12-q13 | 1.60e-04 | 5 | 185 | 2 | 6q12-q13 | |
| Cytoband | Xp21.2 | 4.45e-04 | 8 | 185 | 2 | Xp21.2 | |
| GeneFamily | EF-hand domain containing | MYL1 MYL2 CALB2 CALU SPTAN1 RCN2 EFHD2 RYR2 S100A1 S100A2 MICU3 DST PRKCSH | 2.62e-09 | 219 | 121 | 13 | 863 |
| GeneFamily | Ankyrin repeat domain containing | ANKS6 CTTNBP2 ANK2 UACA POTEF ESPNL ANKRD36C POTEE CASKIN1 OSBPL1A POTEI | 6.89e-07 | 242 | 121 | 11 | 403 |
| GeneFamily | Myosin heavy chains | 2.46e-06 | 15 | 121 | 4 | 1098 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 7.96e-05 | 13 | 121 | 3 | 685 | |
| GeneFamily | RNA binding motif containing | 5.79e-04 | 213 | 121 | 7 | 725 | |
| GeneFamily | Zinc fingers BED-type|Pseudoautosomal region 1 | 6.55e-04 | 6 | 121 | 2 | 64 | |
| GeneFamily | Keratins, type II | 7.61e-04 | 27 | 121 | 3 | 609 | |
| GeneFamily | EF-hand domain containing|Spectrins | 9.13e-04 | 7 | 121 | 2 | 1113 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 9.13e-04 | 7 | 121 | 2 | 761 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.21e-03 | 8 | 121 | 2 | 939 | |
| GeneFamily | DEAD-box helicases | 2.78e-03 | 42 | 121 | 3 | 499 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 3.84e-03 | 14 | 121 | 2 | 657 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | B3GALNT1 PDS5B MYH10 DNAJC13 CTTNBP2 MYO5A STRBP CEP290 WRN RCN2 SMC4 SLC24A3 TRIP11 DDX46 SLC4A1AP RABGAP1L OSBPL1A GKAP1 SMARCA2 TMF1 USP48 | 8.17e-09 | 656 | 184 | 21 | M18979 |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_F | 1.14e-07 | 55 | 184 | 7 | M2043 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 6.82e-07 | 103 | 184 | 8 | M1170 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.54e-06 | 199 | 184 | 10 | M5893 | |
| Coexpression | HALLMARK_MYOGENESIS | 1.62e-06 | 200 | 184 | 10 | M5909 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CARDIAC_MUSCLE_LINEAGES | 5.93e-06 | 182 | 184 | 9 | MM3637 | |
| Coexpression | LEIN_NEURON_MARKERS | 9.16e-06 | 69 | 184 | 6 | M1712 | |
| Coexpression | LEIN_NEURON_MARKERS | 9.96e-06 | 70 | 184 | 6 | MM714 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B HIF1A DNAJC13 WRN NCK1 SPECC1L LRPPRC SETD2 DST AKAP9 RABGAP1L SMARCA2 ROCK1 PHF14 DMD PUM1 ADGRA3 MRTFA LRRFIP1 | 1.03e-05 | 856 | 184 | 19 | M4500 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.04e-05 | 20 | 184 | 4 | M1123 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.27e-05 | 200 | 184 | 9 | M5901 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.28e-05 | 21 | 184 | 4 | MM1102 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 1.38e-05 | 111 | 184 | 7 | MM1111 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_DN | 1.86e-05 | 78 | 184 | 6 | M9814 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | TACO1 PDS5B AARS1 RANGAP1 CALU KMT5A SMC1A PABPC4 MAP3K20 SMC4 EFHD2 ANKRD36C RFC5 GSS KNOP1 ZNF771 THOP1 SLC4A1AP GKAP1 CCDC25 DLST USP48 HDGFL2 TGS1 | 3.19e-05 | 1363 | 184 | 24 | M45782 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 3.76e-05 | 177 | 184 | 8 | M39245 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 4.07e-05 | 179 | 184 | 8 | M39308 | |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_2_UP | RANGAP1 EFHD2 TNFRSF10B ITGA7 RFC5 ACTR2 KNOP1 AKAP9 OSBPL1A RIMS1 PLEC MAPK13 | 4.49e-05 | 420 | 184 | 12 | M3053 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | TPR DNAJC13 ANK2 SPTAN1 SPTBN1 ARMC9 GSS KNOP1 S100A1 AKAP9 RABGAP1L NAT10 DLST USP48 ADGRA3 LRRFIP1 TGS1 | 4.51e-05 | 790 | 184 | 17 | M12490 |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 6.43e-05 | 191 | 184 | 8 | M40019 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP | 7.71e-05 | 196 | 184 | 8 | M5313 | |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 8.50e-05 | 102 | 184 | 6 | M2124 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN | 8.87e-05 | 200 | 184 | 8 | M8600 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | 9.51e-05 | 259 | 184 | 9 | M9331 | |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | B3GALNT1 AARS1 RCN2 CHGB CHN1 ACTR2 RYR2 RTF1 LRPPRC OSBPL1A SYT1 AKT1 PUM1 | 1.39e-04 | 547 | 184 | 13 | M2110 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | PDS5B HIF1A TRA2B MAP2 STRBP WRN RYR2 AKAP9 VCAN MYOCD VCP TGS1 | 2.77e-05 | 330 | 181 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.22e-05 | 186 | 181 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR FAM184A ANK2 MYO5A STRBP SMC1A CEP290 SMC4 CHN1 STK11IP CCDC88C DDX46 AKAP9 NAT10 OSBPL1A RPUSD2 SMARCE1 CCDC25 PHF14 DMD CACYBP CAMSAP1 TGS1 | 3.67e-05 | 1060 | 181 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | FAM184A MYO5A MAP2 STRBP SMC1A CEP290 SMC4 KNOP1 CCDC88C SETD2 DDX46 AKAP9 NAT10 GKAP1 RPUSD2 ROCK1 CCDC25 PHF14 LRBA DMD CACYBP TGS1 | 3.80e-05 | 989 | 181 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.13e-05 | 192 | 181 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | BM Top 100 - tongue superior part w_papillae | 5.86e-05 | 79 | 181 | 6 | BM Top 100 - tongue superior part w_papillae | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | FAM184A MYO5A SMC1A CEP290 SMC4 DDX46 AKAP9 ROCK1 PHF14 LRBA TGS1 | 7.71e-05 | 311 | 181 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | FAM184A MYO5A STRBP SMC1A CEP290 SMC4 CHN1 SETD2 DDX46 AKAP9 SLC4A1AP GKAP1 PHF14 DMD CAMSAP1 USP48 GOLGA1 MRTFA TGS1 | 9.28e-05 | 831 | 181 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | IQSEC3 ANK2 MAP2 IFT57 STRBP CEP290 SMC4 CCDC88C PALS1 DDX46 AKAP9 SLC4A1AP RABGAP1L GKAP1 TMF1 RPUSD2 ROCK1 PHF14 LRBA DMD TGS1 | 1.02e-04 | 983 | 181 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | IFT57 STRBP CEP290 SMC4 SLC24A3 PALS1 DDX46 DST AKAP9 SLC4A1AP GKAP1 TMF1 RPUSD2 PHF14 DMD TGS1 | 1.59e-04 | 654 | 181 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TPR FAM184A ANK2 MYO5A MAP2 STRBP SMC1A CEP290 SMC4 CHGB CHN1 STK11IP CCDC88C DDX46 AKAP9 NAT10 OSBPL1A RPUSD2 SMARCE1 CCDC25 PHF14 PLCB2 DMD CACYBP CAMSAP1 TGS1 | 1.72e-04 | 1414 | 181 | 26 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR FAM184A MYH10 ANK2 TRA2B MYO5A STRBP SMC1A CEP290 SMC4 CHN1 CCDC88C DDX46 AKAP9 SLC4A1AP NAT10 RPUSD2 ROCK1 SMARCE1 PHF14 DMD CACYBP CAMSAP1 TGS1 | 1.79e-04 | 1257 | 181 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | MORC1 RANGAP1 HIF1A DNAJC13 TRA2B SMC1A SPTBN1 SMC4 PABPC4L CHGB STK31 PALS1 WWC2 MACO1 ROCK1 PLEC PUM1 TGS1 | 1.91e-04 | 806 | 181 | 18 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | PDS5B KRT5 HIF1A MYL1 ANK2 TRA2B MYO5A MAP2 STRBP WRN CHGB RYR2 AKAP9 VCAN SYT1 MYOCD VCP TGS1 | 2.29e-04 | 818 | 181 | 18 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | B3GALNT1 TPR FAM184A ANK2 MYO5A MAP2 STRBP KMT5A SMC1A SPTAN1 CEP290 SMC4 CHGB KNOP1 ZNF771 CCDC88C AKAP9 GKAP1 RPUSD2 PHF14 RIMS1 DMD CAMSAP1 ENO3 TGS1 | 2.60e-04 | 1370 | 181 | 25 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.71e-04 | 246 | 181 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.83e-04 | 148 | 181 | 7 | gudmap_developingLowerUrinaryTract_adult_bladder_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#5_top-relative-expression-ranked_500 | 3.14e-04 | 16 | 181 | 3 | gudmap_developingGonad_P2_testes_500_k5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | MYH8 MYL1 STK31 CKM OTOF ITGB1BP2 MYOCD UNC13C RIMS1 DMD ENO3 | 2.27e-10 | 177 | 185 | 11 | c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | MYH10 MAP2 SLC24A3 RYR2 ROCK1 MYOCD UNC13C RIMS1 DMD STK38L LRRFIP1 | 4.32e-10 | 188 | 185 | 11 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | CEP290 SMC4 TRIP11 RTF1 AKAP9 SMARCA2 TMF1 ROCK1 SMARCE1 LRRFIP1 TGS1 | 7.49e-10 | 198 | 185 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 6.51e-09 | 187 | 185 | 10 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-09 | 187 | 185 | 10 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-09 | 187 | 185 | 10 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | TPR CEP290 TRIP11 DDX46 AKAP9 OSBPL1A SMARCA2 TMF1 ROCK1 SMARCE1 | 1.18e-08 | 199 | 185 | 10 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | TPR CEP290 TRIP11 RTF1 DST AKAP9 SMARCA2 ROCK1 SMARCE1 LRRFIP1 | 1.18e-08 | 199 | 185 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.54e-08 | 167 | 185 | 9 | 91b14df450bfb6a2b406c88f8c75cd51eeb9e82b | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-08 | 172 | 185 | 9 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-08 | 172 | 185 | 9 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.56e-08 | 176 | 185 | 9 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-08 | 178 | 185 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 8.14e-08 | 184 | 185 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-08 | 187 | 185 | 9 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 9.78e-08 | 188 | 185 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-08 | 188 | 185 | 9 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-08 | 188 | 185 | 9 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-08 | 188 | 185 | 9 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 189 | 185 | 9 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.02e-07 | 189 | 185 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 189 | 185 | 9 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 191 | 185 | 9 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.28e-07 | 194 | 185 | 9 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.34e-07 | 195 | 185 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.46e-07 | 197 | 185 | 9 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.46e-07 | 197 | 185 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-07 | 198 | 185 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.59e-07 | 199 | 185 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.59e-07 | 199 | 185 | 9 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.59e-07 | 199 | 185 | 9 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-07 | 152 | 185 | 8 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-07 | 152 | 185 | 8 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.34e-07 | 158 | 185 | 8 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.86e-07 | 166 | 185 | 8 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.86e-07 | 166 | 185 | 8 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.83e-07 | 170 | 185 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.65e-07 | 173 | 185 | 8 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.36e-07 | 181 | 185 | 8 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 9.75e-07 | 182 | 185 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 183 | 185 | 8 | 905e1e9be0f15be184447df04b134a6aa8279074 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 183 | 185 | 8 | 92eed783347a372b850de3189e72525082390014 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-06 | 183 | 185 | 8 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.06e-06 | 184 | 185 | 8 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-06 | 185 | 185 | 8 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.10e-06 | 185 | 185 | 8 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.10e-06 | 185 | 185 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 188 | 185 | 8 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 188 | 185 | 8 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.29e-06 | 189 | 185 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.35e-06 | 190 | 185 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 190 | 185 | 8 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.35e-06 | 190 | 185 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 191 | 185 | 8 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 191 | 185 | 8 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 192 | 185 | 8 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 192 | 185 | 8 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 192 | 185 | 8 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 192 | 185 | 8 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.51e-06 | 193 | 185 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.51e-06 | 193 | 185 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 194 | 185 | 8 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 194 | 185 | 8 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 194 | 185 | 8 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 196 | 185 | 8 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 196 | 185 | 8 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-06 | 137 | 185 | 7 | 264d5e06c37d1a9ef7748091b67d2a5aa803096e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-OPC_related-Oligodendrocyte/OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-06 | 137 | 185 | 7 | 8ce463d1d74ac0ce80b812217d6bd76a788f14d2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 197 | 185 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-06 | 199 | 185 | 8 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.90e-06 | 199 | 185 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 185 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 185 | 8 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 185 | 8 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 185 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.98e-06 | 200 | 185 | 8 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.98e-06 | 200 | 185 | 8 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.07e-06 | 161 | 185 | 7 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.96e-06 | 165 | 185 | 7 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.45e-06 | 167 | 185 | 7 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.25e-06 | 170 | 185 | 7 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.25e-06 | 170 | 185 | 7 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-06 | 175 | 185 | 7 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-06 | 175 | 185 | 7 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 176 | 185 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-06 | 177 | 185 | 7 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-06 | 178 | 185 | 7 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.00e-05 | 118 | 185 | 6 | 5f72022f4be3fb7ccec86dc05d37572833028886 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.00e-05 | 118 | 185 | 6 | 053c0986051e36fdc4c48b8067c137b6299b2f1b | |
| ToppCell | Control-Lymphoid_T/NK-NK_activated|Control / Disease group, lineage and cell class | 1.05e-05 | 119 | 185 | 6 | a258d91ac90d4174b6f203d7f96ba6e57c6003e7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-05 | 119 | 185 | 6 | 28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-05 | 119 | 185 | 6 | 0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.05e-05 | 180 | 185 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 181 | 185 | 7 | 09a574a3257e25c8b05a2ab20623a6b07331411a | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 181 | 185 | 7 | ac4142aa93706b7067f63d2d38e2456859e60768 | |
| ToppCell | BAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 1.09e-05 | 181 | 185 | 7 | f370161afef2ec827a7b194c06abb9ac1a507cbb | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 182 | 185 | 7 | edfc598b7199ca1d8a399b264ab863c299b1eede | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| Computational | Neighborhood of TTN | 1.30e-04 | 26 | 110 | 4 | GNF2_TTN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.50e-04 | 50 | 110 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | B0683 | MYH1 MYH4 MYH8 MYH10 MYL1 MYL2 ANK2 MYO5A TMF1 ROCK1 DMD MYO18B | 1.98e-10 | 117 | 184 | 12 | CID006398969 |
| Drug | NSC339663 | MYH1 MYH4 MYH8 MYH10 MYL1 MYL2 MYO5A SYNE1 NCK1 ROCK1 PPP1R9B AKT1 PLEC MYO18B MRTFA | 2.05e-09 | 250 | 184 | 15 | CID000003892 |
| Drug | AC1L1IZ2 | MYH1 MYH4 MYH8 MYH10 MYL1 MYL2 MYO5A EIF4A3 RFC5 PGK2 RYR2 GSS ROCK1 LRBA MYO18B VCP | 3.87e-09 | 304 | 184 | 16 | CID000004795 |
| Drug | formycin triphosphate | 7.39e-09 | 51 | 184 | 8 | CID000122274 | |
| Drug | purealin | 2.12e-08 | 58 | 184 | 8 | CID006419303 | |
| Drug | blebbistatin | 3.62e-08 | 116 | 184 | 10 | CID003476986 | |
| Drug | PTC124 | 6.60e-08 | 27 | 184 | 6 | CID011219835 | |
| Drug | geldanamycin | TPR HIF1A DNAJC13 COL12A1 MYO5A SMC1A SPTBN1 ACTR2 SETD2 DST ZBED6 SMARCA2 AKT1 MYOCD DMD | 3.77e-07 | 371 | 184 | 15 | ctd:C001277 |
| Drug | trifluoperazine | MYH1 MYH4 MYH8 HIF1A MYH10 MYL1 MYL2 MYO5A MAP2 SPTAN1 SPTBN1 S100A1 LRBA MYO18B | 4.23e-07 | 324 | 184 | 14 | CID000005566 |
| Drug | oxovanadium | 5.85e-07 | 120 | 184 | 9 | CID000024411 | |
| Drug | fast white | 1.06e-06 | 42 | 184 | 6 | CID000024008 | |
| Drug | S-(-)-Etomoxir | 1.54e-06 | 100 | 184 | 8 | CID000060765 | |
| Drug | isoproterenol | MYH1 MYH4 MYH8 MYH10 MYL1 MYL2 ANK2 UACA MYO5A CALU RYR2 S100A1 S100A2 CKM VCAN LRBA DMD MYO18B MAPK13 | 2.23e-06 | 669 | 184 | 19 | CID000003779 |
| Drug | clenbuterol | 2.40e-06 | 142 | 184 | 9 | CID000002783 | |
| Drug | 1,2,4-oxadiazole | 6.45e-06 | 33 | 184 | 5 | CID006451463 | |
| Drug | MgCl2 | MYH1 MYH4 MYH8 MYH10 MYL1 MYL2 MYO5A SPTAN1 SPTBN1 TUT1 CDH20 DLST MYO18B | 6.60e-06 | 354 | 184 | 13 | CID000024584 |
| Drug | eye gene | MYH1 MYH4 MYH8 MYH10 MYL1 MYL2 MYO5A TRIM17 ROCK1 AKT1 PLCB2 MYO18B MAPK13 | 1.03e-05 | 369 | 184 | 13 | CID000004782 |
| Drug | Spermine | 1.19e-05 | 63 | 184 | 6 | ctd:D013096 | |
| Drug | D2926_SIGMA | 1.30e-05 | 64 | 184 | 6 | CID006400050 | |
| Drug | tempol | 1.33e-05 | 221 | 184 | 10 | CID000137994 | |
| Drug | Dithiothreitol | 1.71e-05 | 100 | 184 | 7 | ctd:D004229 | |
| Drug | Securinine [5610-40-2]; Up 200; 18.4uM; HL60; HT_HG-U133A | 2.43e-05 | 189 | 184 | 9 | 2729_UP | |
| Drug | fluorobenzene | 2.45e-05 | 43 | 184 | 5 | CID000010008 | |
| Drug | NSC611747 | MYH1 MYH4 MYH8 MYH10 MYL1 MYL2 MYO5A ROCK1 AKT1 LRBA MYO18B MAPK13 | 3.13e-05 | 352 | 184 | 12 | CID000002534 |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; HL60; HG-U133A | 3.23e-05 | 196 | 184 | 9 | 1567_DN | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HT_HG-U133A | 3.36e-05 | 197 | 184 | 9 | 4216_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.36e-05 | 197 | 184 | 9 | 3575_DN | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A | 3.36e-05 | 197 | 184 | 9 | 4796_DN | |
| Drug | Nexus | 3.40e-05 | 152 | 184 | 8 | CID000098527 | |
| Drug | AC1L1KMJ | COL12A1 MYL1 MYL2 ANK2 MAP2 SPTAN1 SPTBN1 LDHAL6B DST ROCK1 AKT1 PLEC LRBA MAPK13 | 3.49e-05 | 476 | 184 | 14 | CID000030956 |
| Drug | nifedipine | MYH1 MYH4 MYH8 MYH10 MYL1 MYL2 MYO5A CYP24A1 CYP27A1 LDHAL6B RYR2 ROCK1 LRBA | 3.51e-05 | 415 | 184 | 13 | CID000004485 |
| Drug | AP23451 | 3.87e-05 | 24 | 184 | 4 | CID011957378 | |
| Drug | N-acetylcysteine | TPR HIF1A CASP14 IFT57 KMT5A LDHAL6B SSRP1 GADD45A GSS CKM SETD2 VCAN SYT1 AKT1 MAPK13 | 4.00e-05 | 546 | 184 | 15 | CID000000581 |
| Drug | 4-chloroaniline | 4.09e-05 | 202 | 184 | 9 | CID000007812 | |
| Drug | mant-GTP | 5.15e-05 | 50 | 184 | 5 | CID000128647 | |
| Drug | plakin | 5.40e-05 | 82 | 184 | 6 | CID000018752 | |
| Drug | hydroxysafflor yellow A | 5.98e-05 | 10 | 184 | 3 | CID006443665 | |
| Drug | 24-oxo-1 alpha,25-(OH)2D3 | 6.50e-05 | 2 | 184 | 2 | CID005283703 | |
| Drug | AC1O5QCG | 6.50e-05 | 2 | 184 | 2 | CID006438785 | |
| Drug | cariporide | 7.06e-05 | 86 | 184 | 6 | CID000151172 | |
| Drug | bromfenacoum | AARS1 MYH10 CTTNBP2 CALB2 SPTAN1 SPTBN1 RCN2 LRPPRC THOP1 DST AKAP9 CASKIN1 VCAN SYT1 ROCK1 PRKCSH | 7.26e-05 | 644 | 184 | 16 | ctd:C013418 |
| Drug | N-ethylmaleimide | MYH1 MYH4 MYH8 MYH10 MYL1 MYL2 MYO5A SPTAN1 SPTBN1 GSS CKM SYT1 MYO18B VCP | 7.48e-05 | 511 | 184 | 14 | CID000004362 |
| Drug | 4-epidoxorubicin | MYH1 MYH4 MYH8 HIF1A MYH10 CASP14 KMT5A SPTBN1 LDHAL6B TNFRSF10B GADD45A CKM VCAN SMARCA2 ROCK1 AKT1 MAPK13 MX2 | 7.50e-05 | 788 | 184 | 18 | CID000001690 |
| Drug | SM-2 | 7.54e-05 | 87 | 184 | 6 | CID000486033 | |
| Drug | Calcifediol | 9.69e-05 | 91 | 184 | 6 | ctd:D002112 | |
| Drug | OD-q | 1.08e-04 | 179 | 184 | 8 | CID000001456 | |
| Drug | 2c5o | KRT5 RANGAP1 SSRP1 GADD45A PGK2 CKM CASKIN1 VCAN LRBA MAPK13 | 1.11e-04 | 284 | 184 | 10 | CID000447956 |
| Drug | 2,3-DPG | 1.28e-04 | 137 | 184 | 7 | CID000000061 | |
| Drug | AC1NRBPQ | 1.28e-04 | 137 | 184 | 7 | CID005288569 | |
| Drug | cefditoren | 1.40e-04 | 13 | 184 | 3 | CID000444006 | |
| Drug | strontium chromate | 1.54e-04 | 99 | 184 | 6 | CID000024599 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 1.62e-04 | 190 | 184 | 8 | 1971_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.74e-04 | 192 | 184 | 8 | 2123_UP | |
| Drug | Nimodipine [66085-59-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.81e-04 | 193 | 184 | 8 | 3103_DN | |
| Drug | creatine | 1.81e-04 | 193 | 184 | 8 | CID000000586 | |
| Drug | candesartan cilexetil | 1.82e-04 | 145 | 184 | 7 | CID000002540 | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; HL60; HT_HG-U133A | 1.87e-04 | 194 | 184 | 8 | 3100_UP | |
| Drug | NSC716727 | 1.94e-04 | 3 | 184 | 2 | CID000402597 | |
| Drug | Complex Mixtures | 1.94e-04 | 3 | 184 | 2 | ctd:D045424 | |
| Drug | NSC-643735 | 1.94e-04 | 3 | 184 | 2 | CID000457943 | |
| Drug | SB 202190; Down 200; 1uM; PC3; HT_HG-U133A | 1.94e-04 | 195 | 184 | 8 | 7058_DN | |
| Drug | Esculetin [305-01-1]; Down 200; 22.4uM; HL60; HT_HG-U133A | 1.94e-04 | 195 | 184 | 8 | 3120_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 195 | 184 | 8 | 7172_DN | |
| Drug | quercetin dihydrate; Up 200; 1uM; MCF7; HG-U133A | 2.01e-04 | 196 | 184 | 8 | 283_UP | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; HL60; HT_HG-U133A | 2.01e-04 | 196 | 184 | 8 | 2441_DN | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.01e-04 | 196 | 184 | 8 | 7124_DN | |
| Drug | STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A | 2.01e-04 | 196 | 184 | 8 | 6380_UP | |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.01e-04 | 196 | 184 | 8 | 1536_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.01e-04 | 196 | 184 | 8 | 3468_DN | |
| Drug | caffeine | CALU SYNE1 CYP24A1 CYP27A1 LDHAL6B EFHD2 RYR2 PPP4R3A CKM PHF14 PLCB2 LRBA DMD MAPK13 | 2.02e-04 | 562 | 184 | 14 | CID000002519 |
| Drug | NSC107658 | 2.03e-04 | 306 | 184 | 10 | CID000002919 | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.08e-04 | 197 | 184 | 8 | 4231_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.08e-04 | 197 | 184 | 8 | 4787_DN | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; PC3; HT_HG-U133A | 2.08e-04 | 197 | 184 | 8 | 5752_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 2.08e-04 | 197 | 184 | 8 | 2169_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; HL60; HT_HG-U133A | 2.15e-04 | 198 | 184 | 8 | 1329_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.15e-04 | 198 | 184 | 8 | 4980_UP | |
| Drug | Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.15e-04 | 198 | 184 | 8 | 5358_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.15e-04 | 198 | 184 | 8 | 3172_UP | |
| Drug | minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA | 2.15e-04 | 198 | 184 | 8 | 1135_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.15e-04 | 198 | 184 | 8 | 1650_DN | |
| Drug | K-Cl | MYH1 MYH4 MYH8 MYH10 MYL1 MYL2 MYO5A CHGB RYR2 CKM SETD2 ROCK1 MYO18B MAPK13 | 2.21e-04 | 567 | 184 | 14 | CID000004873 |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 184 | 8 | 1705_UP | |
| Drug | Zidovudine, AZT [30516-87-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 184 | 8 | 5333_UP | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A | 2.23e-04 | 199 | 184 | 8 | 2402_DN | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; HL60; HT_HG-U133A | 2.23e-04 | 199 | 184 | 8 | 1280_DN | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 184 | 8 | 7331_DN | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.23e-04 | 199 | 184 | 8 | 7133_DN | |
| Drug | oligomycin; Up 200; 1uM; MCF7; HG-U133A | 2.23e-04 | 199 | 184 | 8 | 442_UP | |
| Disease | Adenoid Cystic Carcinoma | 2.58e-06 | 100 | 178 | 7 | C0010606 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 7.42e-06 | 7 | 178 | 3 | DOID:4644 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | MYH1 KRT5 HIF1A ANK2 STRBP SYNE1 SPTAN1 CYP24A1 LDHAL6B DGKE JAKMIP3 SETD2 KRT76 CDH20 AKAP9 OTOF AKT1 LRBA DMD LRRFIP1 | 8.38e-06 | 1074 | 178 | 20 | C0006142 |
| Disease | colorectal cancer, hormone replacement therapy | 1.59e-05 | 88 | 178 | 6 | EFO_0003961, MONDO_0005575 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.51e-05 | 10 | 178 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.56e-05 | 12 | 178 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.56e-05 | 12 | 178 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 5.90e-05 | 13 | 178 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 9.31e-05 | 15 | 178 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE (disorder) | 1.08e-04 | 3 | 178 | 2 | C1832926 | |
| Disease | Duchenne muscular dystrophy (is_implicated_in) | 1.08e-04 | 3 | 178 | 2 | DOID:11723 (is_implicated_in) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.26e-04 | 80 | 178 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | Cardiomyopathies | 1.42e-04 | 130 | 178 | 6 | C0878544 | |
| Disease | Congenital Fiber Type Disproportion | 1.65e-04 | 18 | 178 | 3 | C0546264 | |
| Disease | Meningioma | 1.95e-04 | 19 | 178 | 3 | C0025286 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 2.15e-04 | 4 | 178 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | neutrophil count | DNAJC13 HSP90B2P MYL2 KMT5A SPTBN1 MPZL1 NAP1L4 NCK1 RTF1 SETD2 FAM186A RABGAP1L OSBPL1A SYT1 AKT1 UNC13C PLCB2 LRBA STK38L TGS1 | 2.71e-04 | 1382 | 178 | 20 | EFO_0004833 |
| Disease | neuroimaging measurement | ANO2 MYH10 CTTNBP2 MAP2 SPTBN1 PM20D1 ARMC9 RFC5 KCTD17 PPP4R3A CCDC88C VCAN SMARCA2 SYT1 DLST PRKCSH PLEC | 2.73e-04 | 1069 | 178 | 17 | EFO_0004346 |
| Disease | Epidermolysis Bullosa Simplex | 3.58e-04 | 5 | 178 | 2 | C0079298 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 3.58e-04 | 5 | 178 | 2 | C3281201 | |
| Disease | neuroimaging measurement, brain volume measurement | 3.64e-04 | 286 | 178 | 8 | EFO_0004346, EFO_0006930 | |
| Disease | electrocardiography | FAM184A POTEF SPTBN1 MRPS35 ARMC9 GMEB2 RBM20 GSS MYOCD PLEC MYO18B | 3.98e-04 | 530 | 178 | 11 | EFO_0004327 |
| Disease | Malignant mesothelioma | 5.32e-04 | 109 | 178 | 5 | C0345967 | |
| Disease | brain measurement, neuroimaging measurement | ANO2 CTTNBP2 MAP2 SPTBN1 PM20D1 PPP4R3A CCDC88C VCAN SMARCA2 SYT1 PLEC | 5.42e-04 | 550 | 178 | 11 | EFO_0004346, EFO_0004464 |
| Disease | cardiomyopathy (implicated_via_orthology) | 9.08e-04 | 71 | 178 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | lung volume | 9.89e-04 | 8 | 178 | 2 | EFO_0600046 | |
| Disease | Embryonal Rhabdomyosarcoma | 9.89e-04 | 8 | 178 | 2 | C0206656 | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 9.89e-04 | 8 | 178 | 2 | C0887850 | |
| Disease | Aqueductal Stenosis | 9.89e-04 | 8 | 178 | 2 | C2936786 | |
| Disease | joint hypermobility measurement | 1.03e-03 | 33 | 178 | 3 | EFO_0007905 | |
| Disease | Chronic schizophrenia | 1.27e-03 | 9 | 178 | 2 | C0221765 | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 1.27e-03 | 9 | 178 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | FEV/FEC ratio | FAM184A CTTNBP2 TRA2B MAP2 STRBP PABPC4 MAP3K20 MRPS35 SLC24A3 PABPC4L TUT1 WWC2 IGF2BP2 MICU3 DST CROCC2 MRTFA | 1.28e-03 | 1228 | 178 | 17 | EFO_0004713 |
| Disease | gut microbiome measurement, bone density | 1.29e-03 | 78 | 178 | 4 | EFO_0003923, EFO_0007874 | |
| Disease | uterine fibroid | 1.36e-03 | 199 | 178 | 6 | EFO_0000731 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.44e-03 | 37 | 178 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Cardiomegaly | 1.55e-03 | 82 | 178 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 1.55e-03 | 82 | 178 | 4 | C1383860 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.58e-03 | 10 | 178 | 2 | C1631597 | |
| Disease | temporomandibular joint disorder | 1.58e-03 | 10 | 178 | 2 | EFO_0005279 | |
| Disease | corpus callosum anterior volume measurement | 1.68e-03 | 39 | 178 | 3 | EFO_0010295 | |
| Disease | testosterone measurement | FAM184A ANK2 MYO5A CYP24A1 PABPC4 SLC24A3 TNFRSF10B GSS GRAMD1B THOP1 SLC4A1AP FAM186A MACO1 GKAP1 SMARCA2 MYOCD USP48 | 1.91e-03 | 1275 | 178 | 17 | EFO_0004908 |
| Disease | Uterine leiomyoma | 2.27e-03 | 91 | 178 | 4 | HP_0000131 | |
| Disease | esophageal cancer (is_marker_for) | 2.30e-03 | 12 | 178 | 2 | DOID:5041 (is_marker_for) | |
| Disease | schizophrenia (is_marker_for) | 2.38e-03 | 44 | 178 | 3 | DOID:5419 (is_marker_for) | |
| Disease | Neurodevelopmental Disorders | 2.46e-03 | 93 | 178 | 4 | C1535926 | |
| Disease | Malignant neoplasm of salivary gland | 2.54e-03 | 45 | 178 | 3 | C0220636 | |
| Disease | Coffin-Siris syndrome | 2.70e-03 | 13 | 178 | 2 | C0265338 | |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 2.70e-03 | 13 | 178 | 2 | DOID:14791 (implicated_via_orthology) | |
| Disease | Salivary Gland Neoplasms | 2.88e-03 | 47 | 178 | 3 | C0036095 | |
| Disease | myopathy (implicated_via_orthology) | 3.06e-03 | 48 | 178 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | corpus callosum volume measurement | 3.20e-03 | 100 | 178 | 4 | EFO_0010299 | |
| Disease | QRS-T angle | 3.94e-03 | 106 | 178 | 4 | EFO_0020097 | |
| Disease | Romano-Ward Syndrome | 4.11e-03 | 16 | 178 | 2 | C0035828 | |
| Disease | Small cell carcinoma of lung | 4.27e-03 | 54 | 178 | 3 | C0149925 | |
| Disease | smoking behavior | 4.81e-03 | 341 | 178 | 7 | EFO_0004318 | |
| Disease | microglial activation measurement | 5.48e-03 | 59 | 178 | 3 | EFO_0010940 | |
| Disease | X-12063 measurement | 5.52e-03 | 186 | 178 | 5 | EFO_0021283 | |
| Disease | Cannabis use, age at onset | 5.78e-03 | 19 | 178 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | cancer (implicated_via_orthology) | 5.88e-03 | 268 | 178 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | HMG CoA reductase inhibitor use measurement | 5.90e-03 | 189 | 178 | 5 | EFO_0009932 | |
| Disease | cognitive function measurement, self reported educational attainment | 5.96e-03 | 355 | 178 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | Intellectual Disability | 5.96e-03 | 447 | 178 | 8 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKAELDNELMEGKVQ | 116 | Q13523 | |
| VADGLKKQEEEEMDF | 106 | P31749 | |
| DDMEKLGLAIKESDA | 2256 | Q99996 | |
| IEGIKAEAKALDDMF | 2706 | P13611 | |
| REDAVEAMKALNGKV | 276 | Q9NQ94 | |
| EEKSKELGDVMVDIA | 476 | Q8IWK6 | |
| DNKEAQEMIGALKER | 526 | Q69YQ0 | |
| EMKDKAEILLQVDES | 301 | Q5VSY0 | |
| KMADKDGDLIATKEE | 161 | O43852 | |
| GDLEDINEMIIKQKA | 2501 | P11532 | |
| LMEAGLELEKDLENK | 166 | Q9NQ90 | |
| GEEESAKLQEDMKVK | 766 | Q5T5Y3 | |
| QKQLDDAKEGEMALL | 341 | Q8NB25 | |
| KVGNIEIKDLMVGDE | 46 | P61160 | |
| EKELAIDNIMGEKIE | 316 | Q3KR37 | |
| LELVQKEVADMKDDL | 101 | Q9H0I3 | |
| LKEAVLVKMAEEGEN | 71 | Q9UKD1 | |
| LVKMAEEGENLEAEI | 76 | Q9UKD1 | |
| SLFDEEGAKIVKDIM | 256 | P07205 | |
| LIDEMDLNGDKKLSE | 271 | Q14257 | |
| FGENDAEKVKMEIEK | 1001 | Q09MP3 | |
| LAVAEAMADKAELEK | 311 | P46060 | |
| AMADKAELEKLDLNG | 316 | P46060 | |
| RKENTMAENEAGKEE | 841 | Q5T481 | |
| EEKLGMDDLTKLVQE | 1226 | Q9NTI5 | |
| NKVEIVGMLQEDEKF | 296 | Q6IN85 | |
| VKNEEIDEMIKEAPG | 61 | P10916 | |
| EGELKSMQDLVEDFK | 256 | Q01546 | |
| KTDKEDILMAGALED | 216 | Q86VD1 | |
| EERVAMKEALKGAIQ | 46 | Q6GTS8 | |
| EARVKEEEQKIFGLM | 3056 | Q01484 | |
| TKEMEGDAQKLEVEN | 1731 | Q5JPF3 | |
| ERKVEGDCQEMDLEK | 56 | O60829 | |
| ENEEEEKLAGDMKSK | 126 | Q99733 | |
| EINKDGDREVEEEMK | 406 | A5A3E0 | |
| ETQEAADKAIEKMNG | 146 | Q13310 | |
| MGKEQELVQAVKAED | 1 | Q8WXD9 | |
| MEKQRALVAAKDGDV | 1 | Q6ZVH7 | |
| AEDKEQDKDKEMDVG | 366 | Q58FF3 | |
| KEESLGKMEQELEAR | 191 | Q92805 | |
| IESGKEEGMKIDLID | 251 | Q9NQR1 | |
| FEKGDVMDVIEKPEN | 211 | P16333 | |
| KKARAGVVLEMDEEE | 311 | Q9UKP3 | |
| LMDVEKDELDSGEKI | 2481 | Q03001 | |
| ELQAGKKSLEDQVEM | 161 | P14314 | |
| KLLDAGDLDIEDDMK | 71 | Q16665 | |
| QMLEGRLKEEDKDII | 416 | Q7Z3E5 | |
| KVELEAKVDALMDEI | 286 | P13647 | |
| LDEADEMLNKGFKEQ | 186 | P38919 | |
| FLLGQEAEKEDKMLA | 116 | O75752 | |
| GIKDVETEDLEDKME | 191 | O95786 | |
| EEKIVLLEAQMEEKA | 976 | Q9P219 | |
| QEKEAEEAAKGLPDM | 211 | Q8N5G2 | |
| NKVKNLTEEMAGLDE | 976 | P13535 | |
| MDKDEEALKAAQAEL | 41 | Q8N1A0 | |
| DLDEDKLKGETMDLQ | 101 | Q9BYZ2 | |
| MASEELQKDLEEVKV | 1 | Q9HB71 | |
| EDLEKALAEQGQDMK | 551 | Q5VZ66 | |
| AADLLEKMLELDVDK | 281 | O15264 | |
| VESDLGQMLEEGKKA | 1201 | P50851 | |
| DLEVVLEKKGNMDEA | 311 | Q1ED39 | |
| VEKGETDLIQKAMDF | 866 | P42704 | |
| ENKVKNLTEEMAGLD | 976 | P12882 | |
| LATLGEKMKEEEVEA | 156 | P05976 | |
| TDGNEMVDKKEFLVL | 246 | Q86XE3 | |
| IMQKEADETKLAEEI | 261 | Q9Y6M1 | |
| GDLDKKDASINIENM | 111 | O95297 | |
| RQVSEAEENGKLDMK | 181 | E9PIF3 | |
| MENGEIDQASEEKKR | 881 | Q9BXW6 | |
| ALGSDEMQKFVEDLK | 961 | Q9UPP2 | |
| KLVLDKDMAEEGVLE | 96 | Q8N5Z5 | |
| LIKMEKKEEEENGER | 96 | O94880 | |
| KGENIEDIPKEVLMD | 56 | Q86WR0 | |
| MEKEKAEEKLAGEEL | 566 | Q7Z4V5 | |
| DGLDSEKDKMLVEKQ | 511 | Q8IZQ8 | |
| EKAIEEQMVAAKDVV | 911 | Q9H0A0 | |
| QKELDLMDLVGEDRK | 46 | Q9HC58 | |
| KIVSNGDEQLEKAME | 46 | Q5R372 | |
| LGDLKEEGDVMDKTN | 266 | Q14671 | |
| DIQIGMEDKKGQLEV | 1541 | Q86UR5 | |
| EEEGKKQELDLNSSM | 71 | Q8N3R9 | |
| EINKDGDREVEEEMK | 406 | Q6S8J3 | |
| GEKARKNELAIEDMD | 351 | P36957 | |
| NEMNGLKEENETLKE | 106 | Q8NC74 | |
| EGEEAFLLIQSEKMK | 411 | A0AVF1 | |
| EELEKVKQEMEEKGS | 351 | Q9NWB7 | |
| EESGKEAKQAEMQLL | 106 | Q5T6J7 | |
| EVMKLDNKINEVLAD | 171 | Q07973 | |
| FAIGIKNADEVELKM | 1331 | Q99715 | |
| MKAQEVELALEEVEK | 61 | O15078 | |
| VEENKQLEEGMKEIL | 641 | O15078 | |
| AALEMVVEELKGKAD | 491 | H7BZ55 | |
| IEEAQKLEDVMAKLE | 186 | Q8WZ74 | |
| VFAKDLDEGINAEMK | 296 | Q9HBT6 | |
| QKTERMDKVGDALEE | 11 | P24522 | |
| FGKKLIDEKLEDMEA | 281 | Q02318 | |
| AEVKDMEQLLALGKE | 351 | Q92771 | |
| DLDSGNMEKVIKDEN | 196 | Q6TDU7 | |
| KVEGEIFKLEMLLED | 461 | Q5T1N1 | |
| KMGNFQLVKEIADED | 301 | Q68DC2 | |
| AGLVMKAIIEEGDKE | 581 | O75165 | |
| EGDKEIATKMQELAL | 591 | O75165 | |
| LEEEDLKDMGIVSKG | 381 | Q9NYL2 | |
| GDVDEFKKLRENMLD | 281 | Q9BPY3 | |
| DKNSDGKIEMAELAQ | 76 | P22676 | |
| EEKEDKVIKEMAAQI | 141 | Q86UT8 | |
| VDIDQGADMQKESKE | 106 | Q13683 | |
| DQEKVDKFMIELDGT | 86 | P13929 | |
| VLDAVDDMKIKGQEK | 286 | P52429 | |
| LGLKNMIKEVDEDFD | 131 | Q96C19 | |
| KVGDTEDNMDNILDK | 366 | A6NE01 | |
| NIGELKKEIEEMKQG | 181 | Q7L014 | |
| LIEDVKMAFDRDGEK | 311 | P15882 | |
| GEEMVQALKQLKDSE | 376 | P48637 | |
| KGEDGEMVKLENLFE | 96 | P31944 | |
| DEKKELENLAAMDLE | 651 | P05060 | |
| VVNEGGEKEKMELFV | 4176 | Q92736 | |
| EKQTKVEGELEEMER | 866 | P35580 | |
| KMEIDLKDLEAQIEA | 1621 | P35580 | |
| GLKEMKDSLAEVEEK | 156 | Q32MZ4 | |
| DKLEEGLNDIQEMIK | 736 | Q9HC10 | |
| EAAKKAVEEMNGRDI | 241 | P0CB38 | |
| EELMGKIDEKEEKDF | 221 | Q5VZ72 | |
| DKDNLEEVKMAAVRG | 461 | P0C091 | |
| EAKVEKAQGGQELEM | 571 | Q8TC56 | |
| KDDLEELAAAAQKME | 451 | Q8IZ73 | |
| AAEKNMEINKEELLG | 271 | P82673 | |
| LLKEKAMAEDLGDQD | 516 | Q92541 | |
| AMAEDLGDQDKAKQI | 521 | Q92541 | |
| GKTMKDQALKDDDAE | 111 | P21579 | |
| KEGKEEKEEGEMVEQ | 501 | Q8N1F8 | |
| QKKLEVAMEEEGLAD | 46 | Q9Y2H1 | |
| VAMEEEGLADEEKKL | 51 | Q9Y2H1 | |
| MEDEEKAVEILGNTE | 1 | A0A087WTH1 | |
| DGNLEEMEEEVRLKK | 1331 | P51531 | |
| DKVMKELDENGDGEV | 56 | P23297 | |
| LKVEVDMEKIAAEIA | 276 | Q969G3 | |
| DDLFEDMKDGVKLLA | 51 | Q8NF91 | |
| EKEELERLKSEVNGM | 536 | Q8N5C8 | |
| EEFKLGQLEKAEMLN | 1521 | B5MCY1 | |
| VEMEKKLEKGQSIDD | 361 | P06732 | |
| EEEKVDISEDGMKAL | 191 | P40937 | |
| ALEMAIEAGAEDVKE | 206 | Q9BSH4 | |
| ILDMNEEVERTGKKE | 86 | O75343 | |
| DELEKKDGENVSMKD | 171 | Q96SI9 | |
| ENKVKNLTEEMAGLD | 976 | Q9Y623 | |
| EINKDGDREVEEEMK | 406 | P0CG38 | |
| DGVEDNKLKENMERA | 376 | Q14191 | |
| AELEGRDKDQMLQEK | 516 | Q969V6 | |
| LIKMEQELGDEEYKE | 426 | Q8TEV9 | |
| MKEEGKIREENANDS | 456 | Q08945 | |
| LEGAEAAIKKQEDFM | 1201 | Q01082 | |
| EENVTLDLVAKGDKM | 446 | Q14246 | |
| QEEKEEKAALEKPMD | 521 | O14967 | |
| EKPMDLEEEKKQNDG | 531 | O14967 | |
| LEEEKKQNDGEMLEK | 536 | O14967 | |
| EKMTLDLKDENDAGN | 261 | Q9BXU1 | |
| AEKDDLMGVEDTAKK | 316 | Q8N1B4 | |
| DLLKEKDEQIRGLME | 546 | P82094 | |
| KDEQIRGLMEEGEKL | 551 | P82094 | |
| AKGDLEMKEEEEISE | 16 | Q9BTP6 | |
| QEEMVLLVKGEEDEG | 16 | Q7L3S4 | |
| GALDIEKEKLMLINE | 336 | Q6AWC2 | |
| KKQMAELEEKILAGD | 981 | Q8NB66 | |
| KAEEIANEMIEAAKA | 651 | P49588 | |
| KNMKLADDVDLEQVA | 386 | P55072 | |
| EMLEKIGRLEKELEN | 341 | P12270 | |
| KEEKAEGAAMLELVG | 331 | Q9H6E5 | |
| QLKKIEDLGAAMEEA | 2261 | Q13813 | |
| MEEAEELLLEGKKAL | 1 | Q9H9D4 | |
| EQKKLEGELTEEVEM | 451 | Q14683 | |
| NRVKMVEKEKDALEG | 286 | Q9NTJ3 | |
| LNEDKEIIGFKAEMS | 241 | Q8IYM2 | |
| LGLMDNEIKVAKAEA | 361 | O14763 | |
| DAVNKGLVDKIMVDR | 4471 | Q15149 | |
| EESGNLDEEEIKKMQ | 516 | Q00722 | |
| KKDSVDGELEALMEN | 1711 | Q9BYW2 | |
| LFEMRVDDKDKIEGV | 536 | P11137 | |
| EEKQMVLHEKQDLEG | 1766 | Q8IUG5 | |
| EKVEGERKEAQDMLN | 646 | Q13464 | |
| EEAVQGYKLKLEEDM | 136 | Q9Y577 | |
| EMIVEEFKRDEGKLI | 571 | Q9BZF9 | |
| DVVEEKMVAEGVNKE | 41 | P86452 | |
| MDIGKLKGENEKIVE | 1456 | Q15643 | |
| VDEEGLKKLMGSLDE | 51 | P29034 | |
| IVDVEDLGKIMDHVK | 311 | Q9NV66 | |
| EQDMSVKKGDDLLET | 551 | Q96RS0 | |
| EDFLNSLEKMEDGKL | 201 | P52888 | |
| DEDIEKMEGKKLQLG | 371 | Q86UV5 | |
| DAKEAKERANGMELD | 171 | P62995 | |
| IMADKEVGNKEDAEK | 476 | Q96RL1 | |
| SKKKVEEEEEDGVNM | 771 | Q6EMB2 | |
| EMQEGLLAVKVKEEE | 11 | Q3MJ62 | |
| CEAKQEEIKMEGIDP | 246 | Q9NR64 | |
| IKMFNQDIEKLVEGE | 426 | P20592 | |
| LEDVQKMKDKGEIAQ | 1296 | Q9Y4I1 | |
| ILLEKKMLGEDSDEE | 301 | Q9BWU0 | |
| QSVEENKERMEKLEG | 711 | Q96SB3 | |
| MDKGLGSQNEVKEEE | 21 | Q9HD90 |